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Minimal access approaches in cardiac surgery and for procedures on the aortic valve began to 
develop in the 1990s. Several variations were performed in search of the most appropriate 
technique before the median ministernotomy was established. 
Despite limited exposure, difficult deairing or cardioplegia application and longer surgical 
times were described in the literature, surgeons believed that this technique would reduce 
surgical trauma and bleeding, improve chest stability, reduce pain and respiratory failure and 
shorten hospitalization and costs, while keeping mortality and morbidity low.  
The aim of this retrospective study was to review the techniques of minimal invasive surgery 
on the thoracic aorta in use in Heart Center Leipzig from 1998 to 2011 as well as the 
preoperative circumstances, intraoperative setup and early and late postoperative outcome of 
these patients. The results were to be integrated in the current literature and commented on. 
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All 199 patients who underwent a procedure on the proximal aorta through minimal access 
incision were selected and included in this study.  
The procedures were completed with a standard surgical setup. Perioperative and 
intraoperative data were collected from surgical and discharge reports. 
Elective surgery was performed in 95.5% of the patients. 8.5% were redo procedures. 
Indication for surgery was dilatation of the proximal aorta in 92.5%, accompanied by 
pathology of the aortic valve in 87.9%. Access to the surgical site was L-type partial 
sternotomy in 59.7%. Cannulation for cardiopulmonary bypass was performed mostly through 
the ascending aorta or aortic arch (arterial line) and right atrium (venous line). Intermittent 
antegrade cardioplegia was delivered in all patients. Brain protection strategies for patients 
undergoing aortic arch replacement included hypothermic circulatory arrest and selective 
cerebral perfusion. Following procedures were performed: isolated aortic arch replacement 
(n=1); supracoronary ascending aorta replacement (isolated n=15, combined to aortic arch 
replacement n=8, combined to aortic valve replacement n=37 or combined to both n=10), and 
aortic root surgery (isolated aortic root replacement or repair n=95, aortic root replacement or 
repair combined to aortic arch replacement n=33).     
Cardiopulmonary bypass time was 123 ± 44 minutes. Conversion to full sternotomy was 
performed in 5 patients due to low cardiac output syndrome or bleeding. Thirty-day mortality 
was 5.0% (n=10) and ischemic stroke rate was 2.5% (n=5). Reoperation due to bleeding was 
performed on 13.1% (n=26). The estimated 10-year survival was 76 ± 4%.  
Clinical research to this subject is limited, based in studies with small populations and 
heterogenous procedures. Our study confirms the feasibility of minimal access proximal 
aortic surgery because neither inadequate exposure nor problems with deairing or cardioplegia 
were reported. Surgical times were shorter than described in the literature. Mortality, stroke, 
cardiac and sternal complication rates were low and comparable to the results in the literature. 
We consider that our higher reexploration rate of because of bleeding was caused primarily 
due to pathological coagulation state. We present the first long term results for minimal 
access proximal aortic surgery at 10 years. 
We consider that our results reflect better the risk inherent to minimal access proximal aortic 
surgery than studies with smaller cohorts but recognize it is limited by its retrospective form 
and heterogeneity of the reported procedures. Randomized prospective studies should bring 
more information about the safety of this procedure, but we support ministernotomy as a 
promising access for selected patients. 
GLOSSARY OF ABBREVIATIONS 
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2 GLOSSARY OF ABBREVIATIONS 
 
BMI Body mass index 
CABG Coronary artery bypass graft  
CCT Cranial computed tomography 
CK Creatine kinase 
CK-MB Creatine kinase MB isoenzyme 
CMRI Cranial magnetic resonance imaging 
COPD Chronic obstructive pulmonary disease 
CPB Cardiopulmonary bypass 
CT Computed tomography 
ECMO Extracorporeal membrane oxygenator 
euroSCORE European System for Cardiac Operative Risk Evaluation 
FEV1 Forced expiration volume in one second  
FS Full sternotomy 
FVC Forced vital capacity 
GFR Glomerular filtration rate 
HCA Hypothermic circulatory arrest 
IABP Intraaortic balloon pump 
ICU Intensive care unit 
LCOS Low cardiac output syndrome 
LVEF Left ventricle ejection fraction 
MA Minimal access 
max. Maximum 
med. Median 
min. Minimum 
MS Median ministernotomy 
NSAID Non-steroid antiinflamatory drugs 
OR Operating room 
PAD Peripheral artery disease 
PE Pericardial effusion 
PH Pericardial hematoma 
RS Reexplorative surgery 
SCP Selective cerebral perfusion 
SD Standard deviation 
SIRS Systemic inflammatory response syndrome 
SXI Subxyphoidal incision 
 Mean 
INTRODUCTION 
7 
 
 
3 INTRODUCTION 
3.1 Why minimally invasive access in cardiac surgery? 
As minimal invasive techniques began to develop in other surgical fields in order to minimize 
surgical trauma and improve patients’ recovery, cardiac surgeons felt the urge to accompany 
these progresses. In this context, the first minimally invasive aortic valve replacement was 
published by Rao and Kumar in 1993
1
. 
Quoting von Segesser
2
 on the first years of experience with minimal access aortic valve 
surgery: “the unquestionable aims for a less invasive operation are less morbidity, less 
discomfort, and a reduced hospital stay through an operation which proves equally durable to 
the conventional approach. Such an operation must be carried out without further risk to the 
patient or increased difficulty for the surgeon”2. In the same line of thought, Estrera3 stated: 
“The ideal incision is one that is versatile, simple to perform, has low morbidity, and allows 
adequate exposure”3. While searching for the ideal access to the aortic valve and aortic root 
that would fit this description, several approaches were developed. 
3.2 Searching for the best minimal invasive access to the aortic valve and root 
3.2.1 Evolution of the surgical access 
The first testimony of minimal access surgery on the aortic valve was published in 1993 by 
Rao and Kumar
1
. These authors described a right thoracotomy on two women with severe 
aortic stenosis, starting a new era in cardiac surgery. 
Cosgrove
4
 published 1996 the first essay on minimal access aortic valve surgery on 115 
patients. This author describes initially a right parasternal incision extending from the second 
to the fifth costal cartilage with subsequent resection of the third and fourth costal cartilages, 
division of the pectoralis major muscle and ligation of the right internal thoracic artery
4
. This 
technique was improved by the use of a retractor system, allowing the preservation of the 
right internal thoracic artery and by the repositioning of the costal cartilages to minimize 
thorax instability and reduce lung herniation
5
, but it still showed insufficient exposure, 
sacrifice of internal thoracic arteries
6
, thoracic instability
6,7
 and difficulty converting to 
median sternotomy to deal with complications
6,8
. 
The right anterolateral thoracotomy approach to aortic valve surgery is nowadays still 
performed in some clinics with decent results
9
.  
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Some approaches as the reversed Z sternotomy
10
 or the superior partial paramedian 
sternotomy
11
, were simultaneously developed, but these, like other non-median approaches, 
showed similar complications as the right-sided thoracotomy: slower healing
12
, difficulty to 
perform
3
, lung herniation
12,13
, the need to cannulate the femoral vessels
3,14
, cartilage 
complications
13
 and the need to ligate both internal thoracic arteries
13
 and  did not get enough 
acceptance. Others, like the transverse sternotomy, showed even higher mortality and 
morbidity and were discontinued
15
. 
Partial midsternal incisions, or partial sternotomies, have developed to be the most successful 
minimal invasive approach for aortic valve access since they were first described 1996 by 
Rodríguez
16
. Adding to the advantages of being simple to perform, keeping the integrity of 
the internal thoracic arteries
6,17,18,19
 and allowing rapid conversion to median sternotomy if 
needed
3,6,19,20,21
, this technique also permits central cannulation
18
 as in the standard median 
sternotomy. This eliminates the need to perform additional incisions to cannulate the femoral 
vessels as in non-median minimal access techniques
3,14
, avoiding groin infections
22
 and vessel 
associated complications like dissection, pseudoaneurysm
22
 and stroke
23
, while permitting a 
more physiological and direct arterial flow
22
. 
Several variations of the median minimal access approach were described, all involving the 
partial sternotomy over the midline. These start either at the manubrium (Svensson’s “j”-
sternotomy
24
, inverted “L”-sternotomy6,11,20,25,26 or, for other authors, “J”-sternotomy” 3,6, 
17,21,22,25,27,28
) or at the first or second right intercostal spaces (Svensson’s “J”-sternotomy24, 
reversed ”C” ministernotomy19,29). They extend through the midline to the level of the fourth 
or fifth intercostal space, where the sternum is transversally cut, either through a right 
intercostal space (for the “J” 3,6,17,21,22,24,25,27,28, “j”24, and inverted “L”-incisions6,19,25,29) or 
through its complete width (inverted T sternotomy
13,14,27,30,31
). 
Techniques involving the lower partial sternotomy, as the lower mini-T sternotomy
32
, 
extend through the midline of the sternum from the level of the second or third intercostal 
space where the sternum is transversally cut, separating the sternum and xiphoidal process in 
two
32
, or sparing the xiphoidal process through a deviation of the sternotomy to the right 
side
33
. 
More recently, an upper V-sternotomy
34
, an I-Sternotomy
35
 and a manubrium-limited 
approach
36
 were described to access the aortic valve, but these remain isolated publications. 
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Glauber
22
 described the median ministernotomy as “not surgeon friendly, as it is more 
complex and technially challenging”, but conversion to full sternotomy doesn’t seem to occur 
often. In fact, a good view to the target structures is achieved by most authors
6,21,17,37
. In 
larger series of ministernotomy aortic valve replacement, conversion rate was very low. 
Lehmann
25
 describes four (0.3%) emergency conversions to full sternotomy in his series of 
1714 ministernotomy aortic valve replacement patients, two of them because of poor 
exposure of the aortic root and the other two because of severe bleeding, while in Bakir’s 
series
28
 this was needed in 8 out of 232 patients (2.9%); similar results were achieved by 
Tabata
38
 (24/907; 2.6%), with only 2 patients having to be converted due to insufficient 
exposure
38
. 
In smaller series of patients, conversion rates varied from 0%
17
 up to 10%
39
. Szwerc
21
 
attempted 50 ministernotomy aortic valve replacement and was forced to full sternotomy in 
only one patient (2%) to improve view to the right atrium.  In Aris’39 prospective randomized 
study, the incision of two of the twenty ministernotomy patients (10%) had to be extended to 
full sternotomy. Both these patients died (one due to myocardial failure possibly due to 
insufficient myocardial protection on the basis of a right coronary anomaly, and the other 
because of a coagulopathy after long cardiopulmonary bypass (CPB) to repair lesions on a 
very fragile aorta). Christianson
17
 did not convert any of his 29 patients in the ministernotomy 
group, Mächler
18
 reported on conversion of two of the 60 (3.3%) ministernotomy patients, 
one of them because of severe bleeding from the aortotomy, to name some examples. 
Besides the limited exposure of the whole heart
37
, some problems associated to this technique 
were described. Application of retrograde cardioplegia might only be achieved through 
indirect and challenging techniques (blind placement of the cannula with transesophageal 
echocardiography confirmation
21,40
 or through a transjugular coronary sinus catheter
12
) or has 
to be limited to the antegrade technique in the coronary ostia, as the right atrium is only 
accessible by its roof and the lower right atrium not accessible at all
26
. According to Szwerc
21
, 
myocardial protection could also be weakened by the incapability to apply topical 
hypothermia.  
The relative inaccessibility to the ventricles also makes manual deairing of the heart through 
compression
13,18,25,26,28
 and the evaluation of the volume status
12
 impossible. The use of 
simple techniques as carbon dioxide insufflation in the surgical field
25,28
, aortic needle 
aspiration
13,25,28,40
 and transesophageal echocardiography
21,40
 to confirm the absence of 
intracardiac air bubbles seems sufficient to minimize these problems
12,18,27
.  
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Other disadvantage is the longer surgical time. In fact, most of the authors describe significant 
longer aortic cross-clamp time
13,17,39
  and time on cardiopulmonary bypass
13,17,39
 for minimal 
access aortic valve replacements than conventional techniques. Surgical times published in 
the literature are presented in Table 1. 
 
Table 1: Aortic cross-clamp, bypass- and intervention times for ministernotomy aortic valve 
procedure and conventional procedure in the literature.  
Times are given in minutes (min) or hours (h) as mean ± standard deviation (  ± SD) 
whenever available. 
 
MA – minimal access; FS – full sternotomy. 
 * According to the author, result with statistical significance,  
Bold: minimal access faster than full sternotomy, 
- : No data available. 
 
 
Author, Year 
Aortic cross-clamp (min) Bypass-time (min) Intervention time (h) 
MA FS MA FS MA FS 
Aris39, 1999 70 ± 19* 51 ± 13* 95 ± 20* 69 ± 10* - - 
Christiansen17, 1999 77.9* 46.5* 116.1 ± 11.9* 71.3 ± 6.6* 3.36 ± 0.23* 2.39 ± 0.3* 
Mächler18, 1999 60 57 84 82 3.25 3.1 
Bonacchi40, 2002 51.7 ± 12 52.4 ± 9.8 
“No difference 
found” 
“No difference 
found” 
3.7 ± 0.46* 3.4 ± 0.6* 
Farhat13, 2003 66 ± 14* 48 ± 9* 88 ± 18* 69 ± 10* 2.8 ± 0.4 2.7 ± 0.4 
Mihaljevic12, 2004 77* 86* 110* 124* - - 
Bakir28, 2006 61.8 ± 16.6* 69.5 ± 16.6* 88.8 ± 23.2* 100.2 ± 22.6* - - 
Raja41, 2013 51±24 * 62±28 * 75±37 85±36 - - 
Neely42, 2014 76* 80* 106* 124* - - 
Ariyatnam20, 2015 52.3 ± 16.3* 45.5 ± 8.1* 68.9 ± 14.8* 62.7 ± 10.1* - - 
Lehmann25, 2015 58.3±17.5 - 82.9 ± 26.7 - 2.5 ± 0.68 - 
v.d. Merwe43, 2015 75.5 ± 19.8 - 106.2± 27.0 - - - 
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Although some studies defend a positive learning curve, shown by decreasing surgical times 
with gaining experience
12,18,24,37
 with cardiopulmonary bypass and cross-clamp times 
approaching
27
 or being shorter than
12
 full sternotomy, it is still unclear if this shows clinical 
relevance
12,27
.  
Discussing this topic, Ehrlich
44
 attributes the longer surgical time to a prolonged blood 
stanching due to limited access; Johnston
31
 arguments that the shorter minimal access 
surgeries described by some centers can be due to the fact that more experienced surgeons are 
performing them, while the full sternotomy cases are performed by less experienced surgeons 
as “learning cases”31. 
Despite of the problems already discussed, median ministernotomy was the technique that 
showed the best technical potential to fit the aims of an ideal minimal invasive approach
3
. 
Several authors examined it in order to determine its safety and economic advantages. This 
resulted in a large number of publications, many of them comparing ministernotomy to 
conventional median full sternotomy. 
3.2.2 Does median ministernotomy (MS) show better results than full sternotomy (FS)? 
In the beginning of the research on median ministernotomy for aortic valve surgery, surgeons 
believed that this technique would reduce surgical trauma and bleeding and improve chest 
stability, reducing postoperative pain
14
 and preventing respiratory failure. This would allow 
patients to be extubated, leave the intensive care unit (ICU) and be discharged earlier, 
reducing the associated costs and increasing patients’ satisfaction with a more appealing 
cosmetic result
14
. 
Adequate design of multicenter randomized trials to compare median ministernotomy (MS) 
and full sternotomy (FS) aortic valve replacement is difficult because of lack of a 
standardized approach and both patients’ and surgeons’ preferences45. The discrepancy in the 
results could also be explained by the difference of experience of the involved centers
27
.  
 Mortality 
In general, 30 day mortality in the aortic valve MS groups did not significantly differ from 
mortality of FS series
13,18,20,31,40,42,46
. Bakir’s28 lower mortality in the MS group (2,6% versus 
4.4%) was not statistically significant, while Tabata
38
 described significantly lower mortality 
rate (2.1%) than predicted (4.2%) in the MS group. Lehmann
25
 described an excellent 30 day 
survival rate of 97.8% ± 0.4% in his study of 1714 MS aortic valve replacement patients. 
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For Farhat
13
, most of the complications and deaths occurred in the first 30 patients of the 
series, reflecting a learning curve. Johnston
31
 attributed the lower overall mortality for MS in 
some studies to the careful selection of patients. 
Doll
27
 found initially a lower mortality in the MS group, but after multivariate analysis, 
minimal access was not an independent predictor of survival as were age, hypertension and 
cardiopulmonary bypass time. 
Long term survival in both groups did not differ either
20,42
, although Mihaljevic
12
 did describe 
a significant benefit from the MS group in what concerned the 5 year mortality. 
 Myocardial infarction and stroke 
After having aforementioned the major concerns while performing MS aortic valve 
replacements, it appears of primary concern to assess the risk of complications associated to 
them. 
Myocardial infarction and postoperative heart failure would be expected to occur if 
insufficient myocardial protection would be applied. In spite of the unanimity on the problems 
related to the application of cardioplegia, most of the series report no significant difference 
not only in the rate of myocardial infarction
12,20
 (MS 2.5% vs FS 2.4%
20
; MS 0% vs FS 1%
12
) 
but also in the resulting clinical signs of myocardial ischemia, like low-cardiac-output 
syndrome (LCOS)
47
 or postoperative creatine kinase (CK), its MB isoenzyme (CK-MB) and 
troponin-T levels 5 minutes after release of cross-clamp and at one and 24 hours, as well as at 
fifth postoperative day
26
. Perioperative intraaortic ballon pump implantation was less frequent 
in the MS group, but this was not statistically significant (MS 0.5% vs FS 1.1%)
42
.  
Despite of these consistent reports, the need for inotropic support was significant higher in the 
MS group in Szwerc’s21 matched cohorts of 50 patients each (MS: 38.7% versus FS: 19.6%). 
Farhat
13
 reported on two patients with temporary right ventricular dysfunction after MS aortic 
valve surgery without postoperative raise of troponin levels, which the author suspected to be 
due to air embolism into the right coronary artery. 
If de-airing of the heart is insufficient, cerebral air embolisms may occurr. The techniques 
used to improve de-airing of the left heart chambers are widespread and efficient, as there 
were no significant differences in stroke rate
,12,27,28
 (Bakir
28
: MS 2.1% vs FS 0.7%; Doll
27
: 
MS 6% vs FS 5%; Neely
12
: MS 6% vs FS 5%, or it was even statistically significant lower
42
 
(Mihaljevic
12
: MS 2% vs FS 5%) in MS than in the FS group. 
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Dogan
26
 measured the levels of two indicators of cerebral injury (S-100 calcium-binding 
protein B and neuron-specific enolase) in the serum of both MS and FS groups of patients and 
found no significant differences between them. Furthermore, both groups of patients achieved 
comparable results on neuropsychological tests. 
 Bleeding 
Reduced bleeding after aortic valve surgery through a parasternal incision was an agreeable 
finding for one of the pioneers of this procedure
7
. Cosgrove
7
 recognized not only the smaller 
skin incision but also the avoidance of complete sternotomy per se to be responsible for this. 
According to this author, full sternotomy leads to diffuse bleeding because of fibrinogen 
depletion during extensive mediastinal dissection and because the sternum continues bleeding 
after its reapproximation at the end of the procedure
7
.  
Although the same results were expected in other minimal access approaches like MS, 
reduced bleeding and need of transfusion could only be supported by some authors
18,26,40,42,48
, 
while others did not achieve significant differences comparing ministernotomy to the 
conventional approach
13,17,21,39
. 
In the beginning of the MS experience, Liu
48
 observed a significant lower median 
postoperative drainage in his group of 86 patients undergoing isolated aortic valve 
replacement by MS than in his control FS favoring the minimal access group. These findings 
could be further confirmed by Bonacchi
40
 in his prospective randomized study of minimal 
access aortic valve replacement (40 patients undergoing MS and 40 patients operated through 
FS). This author described significant less mean mediastinal drainage (183 versus 280 
mL/m
2
) and less mean blood transfusions per patient (157 versus 293 mL/m
2
) in the MS 
group, while reporting over significant more patients bleeding over 800 mL (7 versus 0) in the 
FS group. Other prospective randomized trials
18,26
 also achieved a lesser chest tube drainage 
in the MS group than in the FS group (240 versus 495 mL/24h). 
In a retrospective single center review of patients operated on the aortic valve (232 MS and 
274 FS) from Bakir
28
 statistically significant differences favoring MS were only found in 
mean blood loss. The need of red blood cell transfusion and reoperation because of bleeding 
or tamponade were similar in both groups
28
.  
Neely
42
 matched two groups of 116 patients each undergoing reoperative aortic valve surgery 
either through FS or MS and found a significant lower need for transfusion of packed red 
blood cells in the MS group (27.9% versus 20.0%), although the amount of transfused blood 
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per transfused patient didn’t differ in both groups. With MS, the extent of dissection is lower 
than through FS and this could show an advantage among younger patients who would 
eventually require reoperation on the aortic valve
42
 as well as among patients undergoing 
reoperative aortic valve surgery
38
. 
Other authors presented prospective studies with smaller cohorts (25 patients
17
 and 20 
patients
39
 each group) reporting no difference in what concerns blood loss and need for 
transfusion between both groups. According to Christiansen
17
, this could be explained by the 
longer duration of surgery and bypass-time observed in the minimal access group. Other 
somewhat larger comparative retrospective
21
, as well as prospective (50 patients each group
13
) 
studies also failed to prove superiority of minimal access surgery in respect to blood loss
13,21
, 
transfusion
21
 and reoperation because of bleeding
13
. 
A decreasing trend of incidence of bleeding over time was reported by Tabata
37
, showing a 
learning curve for this procedure. 
 Respiratory function 
Respiratory function was directly analyzed by Bonacchi
40
, Aris
39
, Candaele
49
 and Albacker
50
. 
Based on spirometric tests performed on patients undergoing aortic valve replacement either 
through MS or FS preoperatively as well as at the 5
th
, 30
th
 and 90
th
 postoperative days, 
Bonacchi
40
 describes a postoperative deterioration of respiratory function in patients of both 
groups (40 patients each) on the fifth day compared to the preoperative results, with some 
parameter being significantly lower in the FS than in the MS group. FS patients took longer to 
recover their preoperative pulmonary function (3 months) than the MS group (1 month)
40
. In 
contrast, Candaele
49
 reported on the recovery of forced expiration volume in one second 
(FEV1) and forced vital capacity (FVC) to levels comparable to the MS group (15 patients) as 
early as the 30
th
 postoperative day in a group of 16 patients undergoing FS aortic valve 
surgery, although these spirometric parameters did significantly differ on the 4
th
 postoperative 
day.  On the contrary, Aris
39
 found no significant differences on spirometric parameters 
before discharge on both of his randomized groups of 20 patients each (MS versus FS). 
Some parameters other than spirometry allowed investigators to infer on the pulmonary 
function of their patients. Not only lenght of mechanical ventilation support
18,42,40
 but also 
postoperative need of oxygen
40
 have been found to be significantly lower in the MS groups 
than in the FS group, indirectly showing a better preservation of the respiratory function on 
these patients.  
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Svensson
24
 considered that patients with chronic obstructive pulmonary disease and 
deteriorated pulmonary function might benefit from a minimal access like the “j” or “J” 
sternotomy for aortic valve surgery. Because the chest remains stable, the postoperative 
pulmonary function and coughing mechanisms are improved. This idea was also supported by 
von Segesser
2
. 
Other authors
13,21,39
 failed to prove superiority of MS compared to FS for aortic valve surgery 
in respiratory parameter: in his retrospective single centered study, Szwerc
21
 compared two 
groups of 50 patients each undergoing aortic valve replacement either through MS or FS and 
found no significant differences in intubation times between both groups (respectively 14 and 
15 hours). Equivalent results were obtained by Aris
39
 and Farhat
13
 (ventilation time 
respectively 9.9 ± 8 hours
39
 and 12 ± 7 hours
13
 for the MS groups versus 9.9 ± 4.5 hours
39
 and 
14 ± 9 hours
13
 for the  FS groups). 
According to von Segesser
2
, MS reduces the risk to pleural effusion, as there is no need to 
open the pleural cavity during surgery. 
 Pain 
Many authors included this parameter in their comparative studies, as lower pain levels are 
associated to a better respiratory function
49
, allow earlier mobilization
2
 and empirically 
increases patients’ satisfaction and well-being. 
In several studies
18,40
, pain level was measured through pain scales and/or inferred by 
determining the need for analgesic therapy: 
Bonacchi
40
 used a score from 1 (no pain) to 5 (extremely severe pain) at 1 and 12 hours 
postoperatively to assess pain levels
40
. Patients reporting a pain score of 3 (moderate pain) or 
higher were treated with morphine and non-steroid antiinflamatory drugs (NSAID). This 
author reported a significant lower pain level in the minimal access group and lower need of 
morphine in the first 12 postoperative hours as well as NSAID in the first 72 hours
40
. 
Candaele
49
 measured pain levels at rest, after spirometry test and after coughing on 
postoperative days 4 and 30 through a visual analogue scale. On day 4, there were more 
patients with severe pain among the 16 FS patients than among the 15 patients in the MS 
group. This difference turned statistically significant when pain levels were quantified after 
coughing. 
In spite of not being able to show pain reduction in his prospective study of 120 aortic valve 
surgery patients (MS and FS, 60 patients each group), Mächler
18
 found significant differences 
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between both groups favoring MS when analyzing patients needing no analgesic therapy after 
the third postoperative day. Following the same thought, Svensson
24
 described a significant 
lower morphine requirement for patients undergoing MS aortic valve surgery than for FS
24
.  
Contrasting with these statements, Aris
39
 found no significant differences between pain level 
in both minimal access and full sternotomy groups after determining it daily through an 
analytical pain scale. For other authors, the difference of administered analgesic therapy 
administered in both groups was not statistically significant
17,18,21
.  
In a study from Candaele
49
 comparing prospectively 30 patients undergoing either MS or FS 
for aortic valve surgery, pain associated to MS was limited to the incisional area, while 
patients reported about a more global chest pain after FS. 
 Thoracic stability and sternal wound infection 
Thoracic stability is also one of the main factors that led to the development of MS. This is 
known to be a rather rational relationship, as well stated by Tabata
37
. According to this author, 
thoracic stability might be related to a lower risk of deep sternal wound infection, as well as to 
a better respiratory function
38
.  
There are few direct surveys directly comparing sternum stability after MS and FS, but the 
low rate of deep sternal wound infection after ministernotomy reported in some large studies 
(Lehmann
25
: 0.3% of 1714 patients; Tabata
38
 0.5% of 1005 patients) may permit to infer that 
ministernotomy provides a good stability of the chest.  
Although Szwerc
21
 described a higher incidence of soft tissue infection (in 4 of 48 patients) in 
the MS group than in the FS group (none of 51 patients), no patient in the MS group was 
diagnosed with mediastinitis. 
 Length of stay and costs 
In the early days of minimal access surgery, Cohn
14
 analyzed the outcomes of patients 
undergoing minimal invasive cardiac valve surgery and compared them with patients 
undergoing mitral or aortic valve surgery through full sternotomy and found a slight reduction 
in length of stay and costs favoring the minimal invasive group. Although this work included 
not only patients undergoing aortic valve but also mitral valve surgery through respectively 
ministernotomy and a parasternal access, it led to further inquiries from other authors about 
the advantages of ministernotomy for aortic valve surgery in modern health issues. 
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Shorter time to extubation, ICU-  and in-hospital stay are related to a reduction in costs and 
this relation was also found in studies comparing minimal access with full sternotomy aortic 
valve surgery patients, as described by Cosgrove
7
. In fact, this author described the f-stay for 
50 minimal access aortic valve patients through parasternal approach as “rapid” (27 ± 21.6 
hours). When retrospectively comparing a cohort of 40 MS patients with 40 others 
undergoing the same procedure through FS, Cosgrove found a significant reduction of 
postoperative length of stay (5.8 ± 3.0 versus 7.8 ± 6.5 days), which resulted in a 19% 
reduction in direct costs after removing surgical material costs, both favoring the minimal 
access group
7
. 
Doll
27
 and Farhat
13
 also reported about a statistically significant reduction on ICU- stay for 
patients undergoing MS aortic valve surgery than for those undergoing FS. The latter were 
also more likely to have a delayed time to ambulation than the first
27
. 
Shorter in-hospital stay for MS groups was also reported by Bakir
28
 (MS 10.8 ± 7.1 days 
versus 12.8 ± 10.6 days FS groups), Svensson
24
 (MS 6.2 ± 3.2 versus 8.2 ± 2.7 days FS 
groups), Liu
48
 (MS 6.2 versus 9.4 days FS groups) and Raja
41
 (MS 8 vs 12 days FS), although 
the lower ICU-stay favoring the MS group (2.1 ± 2.5 days versus 2.5 ± 5.3 days for the FS 
group) achieved by the first author
28
 did not show statistical significance.  
Other authors
17,21,39
 found no reduction on ICU- stay
17,21
, time to extubation
17
 or overall in-
hospital stay
18,21,39
. Christiansen
17
 relates these findings with the significant longer surgical 
times in the ministernotomy group or to the fact that fast track protocol was not applied to 
these patients. Mächler’s18 patients had the transfer to the rehabilitation center preoperatively 
arranged. 
Another determinant of cost in developing methods is the price of new equipment. Aortic 
valve surgery through MS is possible using simple equipment
18
 that is already available for 
conventional surgery
3,38,39
 and does not require the acquisition of new and expensive tools
2
. 
 Overall patient satisfaction and cosmetic result 
The fact that the incision for MS is significantly shorter than for FS (MS 8.2 ± 1.3 cm versus 
23.7 ± 2.6)
40
 is an important advantage of MS for the many patients
14
 to whom cosmetics still 
is the most important factor for decision making
17
.   
In contrast, Ehrlich
44
 found that, when properly informed about the risk of reduced exposure 
and the mainly longer surgical times for MS, the majority of the studied patients chose to 
undergo FS rather than MS
44
. 
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Patients undergoing MS recovered
24
 and returned to their normal activities (minimal access 
4.6. versus 9.4 weeks conventional surgery)
14
 and to work (minimal access 6.3. versus 8.2 
weeks conventional surgery)
14
 earlier than after FS, and “felt like themselves” after 6.4 weeks, 
while patients undergoing conventional surgery only achieved this after 10.3 weeks
14
. More 
patients in the MS than in the FS groups were discharged home instead as to rehabilitation 
facilities or nursing homes (MS 52.9% versus 65.7% FS)
46
. 
In spite of these apparent profits from MS, quality of life was judged as no different (1.5 in a 
scale from 1 – very good to 6 – poor) in both MS and FS groups17. 
3.3 Surgery on the proximal thoracic aorta: aortic root, ascending aorta and 
aortic arch 
Elective surgery on the proximal thoracic aorta is mainly a prophylactic measure against 
rupture and dissection of a significant or rapid growing thoracic aortic aneurysm
51
.  
According to American College of Cardiology guidelines (2010)
52
, an aneurysm is “a 
permanent localized dilatation of an artery, having at least a 50% increase in diameter 
compared to the expected normal diameter of the artery in question”. An increase in diameter 
under 50% of the expected normal diameter is named ectasia
52
. Proximal thoracic aorta on 
healthy adults should be the widest at the aortic sinus
53
 (male: 32.4 ± 7.7 milimeter (mm), 
female 27.6 ±5.8 mm
53
) and decrease on diameter downstream
51
. An expansion rate of less 
than one mm per decade is expected (male 0.9 mm/decade; female 0.7 mm/decade)
51
, but its 
diameter should not exceed 40 mm
51
. 
Aortic aneurysms result from weakening of the aortic wall due to medial degeneration. 
Medial degeneration occurs also in the normal aging process, but it can be accelerated by 
hypertension
54
. They can be part of the clinical presentation of patients with connective tissue 
disease, as in the Marfan or Ehlers-Danlos syndromes or with familial inheritance without 
overt connective tissue disease. Sporadic aneurysms also occur. High blood pressure, 
atherosclerosis and a bicuspid aortic valve are other known risk factors for the development of 
aortic aneurysms. Other causes for aneurysm of the thoracic aorta surgery include infectious 
(syphilis, tuberculosis, fungal) or non-infectious (large vessel vasculitis, sarcoidosis) 
aortitis
55
.  
Aortic aneurysms may affect any or more than one aortic segment. Most of the aneurysms of 
the thoracic aorta (60%) involve the aortic root and ascending aorta, 40% develop in the 
descending aorta. The aortic arch and thoracoabdominal aorta are involved in 10% each
54
. 
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According to current guidelines
51
,
52
 indication for surgery on the thoracic aorta is generally 
given to patients with or without connective tissue disease who have an aortal diameter 
respectively over 50 mm and 55 mm. This threshold is lowered five millimeters to 
respectively 45 mm and 50 mm for patients with associated risk factors (family history of 
dissection, size increase over 3 mm/year
51
, severe aortic regurgitation, bicuspid aortic valve or 
desire for pregnancy). These or other lower thresholds may also be considered for patients 
who already have an indication for surgery on the aortic valve
51,52,56
 or cardiac surgery at all
52
. 
The stature of the patient should be held in count when applying these criteria
57
. Urgent and 
emergent indications for aortic surgery include endocarditis extending beyond the aortic valve 
to the aortic annulus, acute aortic syndromes and ruptured aortic aneurysm. Other rare 
diseases that require surgery on the thoracic aorta include chronic dissection, intramural 
hematoma, atherosclerotic ulcer, mycotic aneurysm or pseudoaneurysm. 
In spite of the gaining experience on aortic valve surgery through MS and that this access has 
turned routine in many centers
58
, its use for complex procedures requiring a high level of 
surgical skills like surgery on the aortic root
59
, ascending aorta or aortic arch replacement has 
been difficult
60
 and not extensively reported on
61,62
. The existing reports have been limited to 
few centers
58,63
 referring to their experience over a long period of time and including different 
types of surgery on the aorta
63
. MS procedures on the aortic arch remain isolated reports
64
 or 
small populations included in MS aortic valve studies. These papers will be discussed further 
on in the present work (Discussion). In general, these show promising results of the MS 
approach, however, further reports concerning this kind of surgery remain as scarce as the 
safety of this procedure remains unclear. 
3.4 Aims 
The aim of this retrospective study is to review the techniques of minimal invasive surgery on 
the thoracic aorta in use in Heart Center Leipzig from 1998 to 2011 including the 
preoperative circumstances (population description and indication for surgery), 
intraoperative setup (type of incision, cannulation for cardiopulmonary bypass, techniques of 
myocardial protection, performed procedures and surgical times, strategies for brain 
protection),  as well as the early and late postoperative outcome (conversion to full 
sternotomy, low cardiac output syndrome (LCOS), mortality, bleeding, respiratory failure, 
pathological wound healing, neurologic events, length of in- hospital stay, 10 year mortality, 
rate of late aortic related reoperations). 
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4 METHODS 
4.1 Data collection 
Perioperative and intraoperative data were collected from the surgical and discharge reports of 
each patient. Follow-up data were collected through a yearly questionnaire sent by mail.  
As computed tomography (CT)-scan was available to study only for patients undergoing 
surgery later than November 2001, the aortal diameter was collected either from the written 
reports or, if available, from CT-scan (n=110; 55.3%).  
The study was approved by our local Ethics Committee (File number 296-15-24082015).  
4.2 Population 
Between March 1998 and May 2011, 1137 patients underwent surgery on the proximal 
thoracic aorta at the Heart Center Leipzig. We selected all the 199 patients (17.5%) who 
underwent a minimal access incision and included them in our study. 
4.3 Standard procedure  in Heart Center Leipzig  
The decision of minimal access approach was made by the surgeon with the patients’ consent 
in all cases. 
Minimal access surgery on the thoracic aorta was performed under general anesthesia. The 
skin of the thorax was disinfected and the patient was covered in sterile drapes. The sternum 
was divided with an oscillating saw following the J, T or L pattern. 
Once exposed, the pericardium was opened. Cannulation for cardiopulmonary bypass was 
performed after systemic heparinization. The arterial cannula was placed in the ascending 
aorta for more proximal aortal procedures, at the transverse arch, right axillary artery or the 
innominate artery with interposition of a synthetic graft for more distal procedures, or in the 
femoral artery. Venous cannulation and drainage were performed through a single or double 
staged cannula placed in the right atrium. The tip of the double stage cannulas rested at and 
drained the inferior vena cava (cavoatrial technique). If the patient presented with significant 
right-to left shunt or the procedure involved opening of the right heart, a bicaval cannulation 
was performed through direct cannulation of both venae cava. Peripheral cannulation of the 
femoral vein was also performed. Cardiopulmonary bypass was started.Then, the aorta was 
clamped (beginning of cross-clamp time) and cardiac arrest was achieved after the infusion of 
either a crystalloid or a blood cardioplegia solution. Cardioplegia solutions were applied in an 
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antegrad (through the aortic root or directly in the coronary ostia) a retrograde (through the 
coronary sinus) or a mixed manner. A vent-cannula was placed usually in the right upper 
pulmonary vein to drain the blood returning to the ventricles through the bronchial and 
Thebesian veins and return it to the extracorporeal circuit. In parallel, systemic cooling was 
initiated and regulated to the desired level.  
The surgical field was then prepared for the actual procedure. The simplified description of 
some of the performed procedures follows.  
Supracoronary ascending aorta replacement:  
The ascending aorta was removed and a synthetic graft tube (MAQUET® Hemashield 
Platinum) was sutured to both free ends of the aorta distally to the coronary arteries, that 
remained untouched, and proximally to the aortic arch. 
Combined replacement of the aortic valve and the ascending aorta: 
- Separated aortic valve replacement and supracoronary ascending aorta replacement was 
performed if the patient presented with a pathological aortic valve and an aneurysma of the 
ascending aorta, but whose aortic root was normal. 
- Modified Bentall procedure: the whole aortic root and the ascending aorta were replaced by 
a synthetic tube graft with incorporated aortic valve prosthesis. The coronary arteries 
surrounded by a margin of aortic tissue were reimplanted in the synthetic tube graft as “aortic 
buttons”. 
Valve sparing root replacement: 
These techniques were performed on patients with normal aortic valves and dilatation of the 
aorta below the sinotubular junction. 
- David reimplantation procedure: the synthetic tube graft was sutured at the normal 
ventriculo-aortic junction (aortic annulus) and the native aortic valve was fixed inside it. The 
coronary arteries were then implanted to the graft as “aortic buttons”. 
- Yacoub remodeling technique: a synthetic tube graft was tailored with three longitudinal 
cuts and rounding of its ends, creating three tongues of synthetic graft that replaced the aortic 
sinus. This shaped graft was then sutured to the remnants of the aortic sinus along the aortic 
cusps and commissures and the coronary arteries were reimplanted to the graft as “aortic 
buttons”. 
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Aortic arch replacement:  
- Partial aortic arch replacement or hemi-arch technique: the aorta distally to the innominate 
artery was replaced by an oblique carved synthetic tube graft, suturing it to healthy aortic 
tissue, without involving the arch vessels. 
- Total aortic arch replacement: the whole aortic arch was replaced by a synthetic tube graft, 
with reimplantation of its branches. These were sutured either one by one directly in the graft 
or to a special branched synthetic tube graft – separated branched graft technique, or en-bloc, 
suturing the aortic cuff containing the aortic arch branches to a side orifice of the tube graft.  
Cerebral protection was performed through mild, moderate or deep hypothermia associated or 
not with selective brain perfusion, either retrograde through cannulas inserted in the jugular 
vein, or antegrade through cannulas inserted in the innominate or left carotid arteries 
(unilateral selective perfusion) or both (bilateral).  
After performing the procedure, the aorta was unclamped and the heart deaired  (end of cross-
clamp time). Reperfusion phase started, with the surgeon performing bleeding control. The 
patient was then weaned from cardiopulmonary bypass. Venous and aortic cannulas were 
removed and the insertion sites sutured. 
Temporary pacing wires were positioned on the epicardium of the right ventricle of some 
patients. Pericardium was either closed or left open and chest tubes were placed. Stainless 
steel cerclage wires were used to adapt the sternal halves together. Then, subcutaneous tissue 
was closed with running sutures and the skin sutures were performed with absorbable running 
suture or with clips. 
4.4 Definitions 
Operative mortality was divided into 30-day mortality (early mortality)
65
 and in-hospital 
mortality. The last includes all patients who died without having been discharged from the 
hospital after surgery. 
Preoperative status was defined as emergent if the surgery was required without delay for 
ongoing, refractory or unrelenting compromise and not responsive to any other form of 
therapy except surgery, as urgent if surgery was required during the same hospitalization in 
order to minimize further clinical deterioration. Elective surgeries involved stable patients 
whose procedure could be postponed without increased risk of compromised cardiac 
outcome
66
. This classification is similar to the definition from the Society of Thoracic Surgery 
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on their “data specification” document 67. The preoperative status of each patient was either 
stated in the surgical report or could be inferred by the clinical situation of the patient.  
Neurologic events were classified as postoperative new central neurologic deficits, including 
temporary and permanent as well as focal and global deficits
65
. Two distinct groups were 
defined. Stroke was defined as an over 72 hours lasting or permanent neurologic deficit or a 
radiographic imaging diagnosed lesion with transient or permanent symptoms
65,68
. Reversible 
symptoms of short duration (under 72h) without radiologic correlate were defined as 
temporary neurological deficit
68
.  
Respiratory failure was defined as the need for ventilation for in total more than 72 hours in 
the whole postoperative in-hospital stay
69
.  
The preoperative risk was assessed with the additive euroSCORE II (European System for 
Cardiac Operative Risk Evaluation) and classified as low (score ≤ 2), medium (3 ≤ score ≤ 5) 
and high (5 < score)
70
.  
Renal impairment was classified as moderate (85<glomerular filtration rate (GFR)≥50 
mL/min) and severe (GFR<50mL/min), according to the euroSCORE II definition, with GFR 
being calculated with the Cockroft-Gault Equation
70
. 
Hypothermic degrees were defined as in the consensus on hypothermia in aortic arch 
surgery
71
 from March 2013: profound hypothermia <14°C, deep hypothermia 14.1-20°C, 
moderate hypothermia 20.1.-28°C, mild hypothermia 28.1-34°C
71
. 
Low cardiac output syndrome (LCOS) was defined as the need for mechanical support either 
with extracorporeal membrane oxygenator (ECMO), intraaortic balloon pump (IABP) or 
other form of assist device. 
4.5 Statistics 
Continuous variables are expressed as:  
- mean ± standard deviation: ± SD; 
- median: med;  
- and/or range (minimum (min.) – maximum (max.)). 
Categorical data are expressed as number of cases (proportions): n (%).  
Data were inserted and statistical analyses were performed using SPSS Statistics for 
Windows, version 17.0 (SPSS Inc., Chicago). 
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5 RESULTS 
5.1 Preoperative data 
5.1.1 Population description 
Between March 1998 and May 2011 a total of 199 patients underwent minimal access 
proximal thoracic aortic surgery. The mean age was 55 ± 15 years and 138 patients (69.5%) 
were male. Sixteen patients already had undergone surgery on the aortic valve or proximal 
aorta, including one patient after 4 times aortic valve replacement and one patient after 
thoracoabdominal aorta replacement. One other patient had been submitted to coronary artery 
bypass operation. 
The detailed description of the population is presented in Table 2. 
5.1.2 Indication for Surgery 
One hundred and ninety patients (95.5%) underwent elective surgery. The remainder of cases 
(4.5% n=9) had urgent surgery: two patients were diagnosed with endocarditis of the aortic 
valve and root, one patient had a Stanford type-B dissection, two patients had suture 
dehiscence of a previously implanted synthetic tube graft resulting in aneurysm spurium in 
both and contained rupture in one patient. The remaining four patients had urgent surgery due 
to symptomatic aortic valve disease and reduced left ventricular function. No patient required 
emergency surgery. The indications for surgery on the aorta are listed in Table 3. 
Endocarditis was found on 2% (n=4). Two patients presented with an infected aortic valve 
prosthesis and paravalvular abscess and had urgent surgery. Other two patients had elective 
surgery and chronic endocarditic remnants were found intraoperatively on their native aortic 
valves. 
Dissection occurred in 2.5% (n=5) patients. One patient had a Stanford type-B dissection with 
entry-site between left carotid artery and left subclavian artery and a stenotic aortic isthmus. 
The other four patients had already had replacement of the proximal thoracic aorta and 
presented with proximal or distal suture line dissection. For two of these patients this was a 
chronic condition and they underwent elective surgery. 
Aortic diameters were available in 125 (62.8%) patients. For the remaining 74 patients there 
was neither a preoperative CT-scan in the imaging databank nor the aortic diameter was 
specified in the surgical or discharge reports. The mean diameter of the aorta at its widest 
point was 49.0 ± 6.9 mm (range 30 – 80 mm).  
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Table 2: Population description.  
Results are presented as n (%) unless otherwise indicated. 
 n (%) 
Age (years)*  55 ± 15 
Female 61 (30.5%) 
Marfan Syndrome 6 (3.0%) 
Hypertension 119 (59.8%) 
Diabetes 9 (4.5%) 
BMI > 30 29 (14.6%) 
Smoker 49 (24.6%) 
COPD 7 (3.5%) 
Moderate renal impairment 31 (15.6%) 
Severe renal impairment 7 (3.5%) 
Preoperative hemodialysis 1 (0.5 %) 
PAD 1 (0.5%) 
LVEF < 45% 13 (6.5%) 
Previous stroke 7 (3.5%) 
Prior cardiac surgery 17 (8.5%) 
CABG surgery 1 (0.5%) 
Aortic valve or aorta 16 (8.0%) 
additive EuroSCORE II* 5.0 ± 2.0 
 
* Results are  ± SD. 
 
BMI – body mass index; COPD – chronic obstructive pulmonary disease; LVEF –  left 
ventricular ejection fraction; PAD – peripheral artery disease; CABG – coronary artery 
bypass. 
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Table 3: Indication for surgery on the proximal thoracic aorta. 
Results are presented as n (%). 
 n (%) 
Dilatation of the proximal thoracic aorta 184 (92.5%) 
Isolated 24 (12.1%) 
With aortic valve pathology 175 (87.9%) 
Stenosis 64 (32.1%) 
Regurgitation 68 (34.2%) 
Combined 43 (21.6%) 
Dissection 5 (2.5%) 
Acute endocarditis 2 (1.0%) 
Aortic valve disease associated to 8 (4.0%) 
Small aortic root 3 (1.5%) 
Calcified aortic root 5 (2.5%) 
 
5.2 Surgery 
5.2.1 Overall 
Anesthetic and monitoring parameters obeyed the standards pursued in all renowned cardiac 
surgery centers and were considered beyond the scope of this work. These surgeries were 
performed by a small number of very experienced surgeons. 
5.2.2 Sternotomy 
All 199 patients were operated through partial sternotomy (L-type: 59.7% (n=119); T-type 
25.7% (n=51); J-type 1% (n=2). In 13.6% (n=27) the type of partial sternotomy was not 
described). No more details about the extent of the sternotomy were given. 
5.2.3 Cannulation  
Cardiopulmonary bypass was established in all patients. The arterial cannula was placed in 
the ascending aorta or aortic arch (81.4% n=162), femoral artery (15.1% n=30) or right 
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axillary artery (3.5% n=7). Venous cannulation was performed through the right atrium either 
directly with a double stage cannula (64.8% n=129) or percutaneously through the femoral 
vein (33.2% n=66). Bicaval venous cannulation was performed in 4 patients (2%), two of 
them had a relevant atrium septal defect that was closed in same surgery. 
5.2.4 Myocardial protection 
Intermittent antegrade cardioplegia was delivered in all 199 patients. The solutions applied 
included cold cristalloid cardioplegia and cold blood cardioplegia in respectively 85.9% 
(n=171) and 14.1% (n=28). Cardioplegia was administered after aortotomy either in the aortic 
root (48.2% n=96) or through the “hockey stick” technique directly in the coronary ostia 
(51.8% n=103). The mean minimal temperature reached was 29.4 ± 5.4 °C for all patients, 
including patients with aortic arch surgery. 
5.2.5 Brain protection 
Aortic arch replacement was performed in circulatory arrest in all cases. For aortic arch 
replacement (26.1% n=52) brain protection was achieved through hypothermic circulatory 
arrest (HCA) with or without selective cerebral perfusion. The mean lower temperature 
reached for aortic arch replacement was 22.5 ± 4.1°C. Details are presented in Table 4. 
Selective cerebral perfusion (SCP) was performed in 16 patients (8%), all undergoing aortic 
arch replacement. Antegrade selective unilateral technique was used in 2 patients (1%), both 
undergoing total arch replacement. This was achieved through the cannulation of the left 
carotid artery on the Stanford type-B dissection patient and through the left subclavian artery 
while blocking the right common carotid artery with a Fogarty catheter on the second patient. 
Antegrade selective bilateral technique was the most used cerebral perfusion technique (4% 
n=8). Direct cannulation of both common carotid arteries was performed in two patients (1%) 
undergoing total aortic arch replacement, while cannulation of the brachiocephalic trunk and 
right carotid artery was used on 6 patients (3%).  
Retrograde selective cerebral perfusion through the vena cava superior or right jugular vein 
was the chosen technique on 6 patients (3%), all of them undergoing partial aortic arch 
replacement. 
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Table 4: Brain protection for aortic arch replacement.  
Results are presented as n (%).   
 n (%) 
Partial arch replacement 43 (21.6%) 
HCA alone  
Deep hypothermia 6 (3.0%) 
Moderate hypothermia 22 (11.1%) 
Mild hypothermia 2 (1.0%) 
HCA with SCP  
Deep hypothermia 2 (1.0%) 
Moderate hypothermia 7 (3.5%) 
Mild hypothermia 4 (2.0%) 
 
Total arch replacement 
 
9 (4.5%) 
HCA alone  
Deep hypothermia 5 (2.5%) 
Moderate hypothermia (21°C) 1 (0.5%) 
HCA with SCP  
Deep hypothermia 2 (1.0%) 
Moderate hypothermia 1 (0.5) 
 
HCA – hypothermic circulatory arrest, SCP – selective cerebral perfusion. 
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5.2.6 Surgical procedure on the thoracic aorta 
The performed procedures included supracoronary ascending aorta replacement and aortic 
root surgery. Ascending aorta replacement was performed isolated (7.5% n=15), combined to 
aortic arch replacement (4% n=8), combined to aortic valve replacement (18.6% n=37) or 
combined to both aortic arch and aortic valve replacement (5.0% n=10). Aortic root 
replacement or repair was performed isolated (47.7% n=95) or as a combination to aortic arch 
replacement (16.6% n=33). One patient (0.5%) underwent isolated aortic arch replacement. 
Details are presented in Table 5. 
During total arch replacement, brachiocephalic vessels were reimplanted as a complete islet in 
5 patients (2.5%), as independent vessels in 1 patient (0.5%) and as combined islet (left 
subclavian artery and combined left carotid and brachiocephalic trunk) in 3 patients (1.5%). 
  
 
Table 5: Surgical procedures.  
Data are presented as n (%).  
 n (%)  
Isolated aortic arch replacement 1 (0.5%)  
Ascending aorta replacement 198 (99.5%)  
With aortic arch surgery 51 (25.5%)  
Partial 43 (21.5%)  
Total 8 (4%)  
With aortic valve surgery 175 (87.5%)  
Valve replacement 47 (23.5%)  
Bentall procedure 107 (53.5%)  
Valve repair 21 (10.5%)  
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5.2.7 Concomitant procedures 
Additional to the procedure on the proximal thoracic aorta, mitral valve repair was performed 
because of relevant mitral valve regurgitation on three patients (1.5%). For two patients, 
mitral valve regurgitation was the main surgical indication. The mitral valve was reached 
through a left atrial dome incision after resection of the aortic valve and repaired by  
placement of Medtronic Physioring® in 2 patients and a Cosgrove ring® and chordae 
replacement in 1 patient.    
Four patients (2%) underwent D-pattern Maze procedure (isolation of each pulmonary vein 
and ablation line to the mitral valve) in two patients in combination with mitral valve repair. 
 Twenty three Morrow septum myectomies were performed, two through a left atrial dome 
incision, the remaining through the aortic valve. Two atrium septal defects were sutured 
through an incision on the right atrium.  
Coronary artery bypass was performed because of low cardiac output syndrome on 3 patients 
(1.5%).  
5.2.8 Surgical times 
Surgical times were reported for all patients and are illustrated in Figure 1. 
Total surgical time (Figure 1A) was 218 ± 65 min (range 113 – 585 min), cardiopulmonary 
bypass time (Figure 1B) was 123 ± 44 min (range 52 – 391 min), cross-clamp time (Figure 
1C) was 81 ± 26 min (range 28 – 177 min). For patients undergoing aortic arch replacement, 
circulatory arrest time (Figure 1D) was 15 ± 7 min (range 7 – 54 min).  
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Figure 1: Distribution frequencies for surgical times for all patients. 1A: total surgical time, 
1B: cardiopulmonary bypass time, 1C: aortic cross clamp time, 1D: circulatory arrest time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3 Intraoperative complications and early results 
5.3.1 Conversion to full sternotomy 
Conversion to full sternotomy was needed in 5 patients (2.5%). 
Hemorrhage was the cause of conversion in 2 patients (bleeding site from the aortic root  and 
left auricle). These patients could be discharged on days 11 and 76. Another patient became 
unstable on the basis of a cardiac dysrhythmia. This patient died on day 11. Conversion to full 
sternotomy occurred because of low cardiac output in 2 patients. Both needed an intraaortic 
balloon pump (IABP) and an aorto-coronary bypass in order to be stabilized (one to the right  
coronary artery because of its narrowing  by a stich at the aortic annulus and the other patient 
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left internal thoracic artery to left anterior descending artery because of hypokinesia  of the 
anterior wall). The first patient died on day 15 after implantation of ECMO and right 
ventricular assist device implantation and the second patient was discharged on day 115. 
5.3.2 Low cardiac output syndrome (LCOS) 
Mechanical circulatory support because of LCOS was needed on 6 patients (3%). Five 
patients had already developed LCOS on surgery. A venous bypass to the right coronary 
artery and ECMO was needed in one patient  who presented with severe aortic valve stenosis, 
reduced left ventricular function and a strongly hypertrophied left ventricle. ECMO could be 
removed some hours after surgery and the patient was transferred to the ward on day 5 and to 
the rehabilitation center on day 14. The second patient had a severely reduced left ventricle 
ejection fraction (LVEF) of 24%, could not be stabilized with IABP and ECMO and died on 
day 3. The third patient suffered air embolism to the right coronary artery, was stabilized with 
IABP which could be removed on day 4 and the patient left the hospital on day 18. Another 
patient had LVEF of 30%, weaning from cardiopulmonary bypass was only successful with 
high catecholamine therapy. ECMO and IABP were implanted after surgery and a 
biventricular assist device on the following day. This patient died on day 17 because of 
cerebral bleeding. The fifth  patient had a narrowing of the right coronary artery caused by a 
stich at the aortic annulus, was converted to full sternotomy and had a venous bypass placed 
to the right coronary artery and IABP implantation. A right ventricular assist device and 
ECMO was placed, but the patient did not recover from LCOS and died on day 15. 
On the remaining patient, coronary artery bypass with internal thoracic artery to the left 
coronary artery was performed because of hypokinesia of the anterior wall after conversion to 
full sternotomy. IABP therapy was needed until day 2. This patient had a prolonged 
postoperative stay on ICU with of respiratory failure and temporary hemofiltration, but 
transfer to the rehabilitation center was possible on day 115.   
5.3.3 Mortality 
Early mortality was 5% (n=10). Eight patients died in our clinic, one died after transfer to 
neurosurgical clinic and one after being discharged to therehabilitation center. 
Two patients (1.0%) died due to low cardiac output syndrome on postoperative days 3 and 15, 
despite mechanical circulatory support. Both patients already presented with severe left 
ventricular dysfunction, the last needing a bypass to the right coronary artery intraoperatively.  
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Two patients (1%) died on day 6 and 17 due to intracerebral bleeding requiring neurosurgical 
intervention. The second patient had also had low cardiac output syndrome and an implanted 
biventricular assist device. 
Sepsis was the cause of death for three patients (1.5%). Fungal and bacterial sepsis caused 
circulatory failure in one  patient (death on day 18), the second patient developed peritonitis 
after colostoma placement because of abdominal compartment syndrome (death on day 25) 
and the third patient had pneumonia and acute respiratory distress syndrome requiring prone 
positioning (death on day 11).  
Two patients (1.0%) died because of hemorrhagic shock, both needing cardiopulmonary 
reanimation and rescue reoperation due to hemodynamic relevant hemorrhage in the first 
postoperative hours. For both patients, blood loss was originating from the suture site on the 
distal anastomosis from the tube graft with the native aorta and both had to be placed on 
cardiopulmonary bypass and aortic cross-clamp to repair the bleeding. One patient had severe 
cerebral damage as a consequence and died on the first postoperative day and the other died in 
the operating room (day 0) following unsuccessful repair of a very fragile and continuously 
tearing aorta. 
One patient died on day 13 after supracoronary ascending aorta and aortic valve replacement 
and Morrow septum myectomy one day after being discharged to rehabilitation facility. The 
cause of death is unknown.  
Operative mortality (5.5% n=11) includes one more patient who died after day 30 without 
having been discharged from the hospital. Indication for surgery was suture line dissection 
and the suspicion of an infected tube graft after a fungal sepsis. This patient developed 
mediastinitis and septic shock with multiple cerebral septic infarcts. Because of severe 
cerebral injury, this patient did not undergo redo surgery on a suspected hematoma from the 
proximal anastomosis and died on day 38.  
5.3.4 Bleeding 
Reoperation due to bleeding or hematoma on surgical site was performed on 26 patients 
(13.1%), These cases are described in Table 6. 
 Seventeen patients (8.0%) had a recognizable hemorrhage source, either from the distal 
anastomosis (3.0% n=6), from the proximal anastomosis or aortic root (3.0% n=6) or from 
other locations (2.5% n=5: left auricle, circumflex artery, right coronary artery button or 
retrosternal (two patients)). Four patients (2.0%) presented diffuse bleeding due to 
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coagulopathy and for 5 patients (2.5%) neither bleeding source nor coagulation status was 
described on the reexplorative surgery report. Nineteen patients (9.5%) reentered the 
operating room on the same day as the initial surgery and four (2%) on the first postoperative 
day. Three patients had reexplorative surgery respectively on postoperative days 8, 10 and 13. 
 
Table 6: Description of cases undergoing reexploration surgery because of bleeding on 
surgical site. 
Bleeding source Conversion to FS on RS Re-CPB on RS Specifics 
Proximal anastomosis, dorsal No No ECMO 
Coagulopathy No No Died day 38 
Proximal anastomosis No No Marfan 
Distal anastomosis Unknown No  
Left auricle No No  
Retrosternal Conversion on first surgery No  
Retrosternal + coagulopathy Unknown No ECMO+IABP / multiple RS / Died day 17 
Proximal anastomosis No No  
Distal anastomosis Unknown Yes Died day 1 
None described Conversion on first surgery No IABP / died day 15 
Circumflex artery Yes Yes  
None described SXI No PH 
Distal anastomosis, dorsal No No  
None found No No Recurrent PE/PH 
Proximal anastomosis No No  
Proximal anastomosis Yes Yes Died day 18 
Proximal anastomosis No No  
Right coronary button No No  
None found No No  
Distal arch anastomosis No No  
Distal anastomosis Yes Yes Died in OR day 0 
Coagulopathy No No  
None described SXI No PE 
Coagulopathy No No  
Coagulopathy No No  
1st: Distal Anastomosis 
2nd: None found 
1st: No 
2nd: SXI (PE) 
No Twice reexploration 
 
FS – full sternotomy; RS – reexplorative surgery; ECMO – extracorporeal membrane 
oxygenator; IABP – intraaortic balloon pump; SXI – subxyphoidal incision; PH – pericardial 
hematoma; PE – pericardial effusion; OR – operating room. 
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5.3.5 Respiratory failure 
Time or day of extubation was stated in 174/199 reports (87.4%). All 10/199 patients (5.0%) 
who died in the hospital died intubated and ventilated. Three died before completing 72 hours 
after surgery, the other seven were considered to have respiratory failure. 
Respiratory failure (total ventilation time >72 hours) occurred in 20/174 patients (11.5%). 
8/174 patients (4.6%) were extubated later than 72 hours postoperatively and 12/174 patients 
(6.9%) were reintubated and had a total ventilation time over 72 hours. 
Four of the 154 patients with less than 72 hours total ventilation time were reintubated. For 
three of these patients this was due to reoperations (bleeding, placement of pleural tube in the 
operating room and sternal refixation). The remaining patient developed respiratory failure 
associated to abdominal pain and ileus. Pneumonia was diagnosed on 6/199 patients (3.0%). 
Excluding three patients who died before completing 72 hours after surgery, total ventilation 
time was under 24 hours in 151/171 patients (87.7%). Excluding the patients who died 
without extubation, mean time to first extubation was 18 ± 30 hours. 
Four of all patients (2%) were tracheotomized. 
5.3.6 Pathological wound healing 
Sternal reoperation was needed in 6 patients (3.0%). Refixation surgery without wound 
infection was performed in 3 patients (1.5%). In one of these patients, delirium caused 
breaking of all sternal wires. Two patients (1.0%) had superficial wound infection and needed 
surgical debridement. An infective agent coud not be isolated from the wound swabs from 
neither.  
Deep sternal wound infection was diagnosed in one patient (0.5%) who had had fungal sepsis 
in the past. On day 15, the sternum showed infection signs and was surgically debrided. 
Purulent discharge was described on the surgical report, but no infectious agent could be 
identified. This patient died on day 38 after developing sepsis, cerebral septic infarcts and a 
large mediastinal hematoma.  
5.3.7 Neurologic Events 
All patients with suspected neurological complications on physical examination underwent 
cranial computed tomography (CCT) scan or cranial magnetic resonance imaging (CMRI). 
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Ischemic stroke with imagiologic correlate occurred in 5 patients (2.5%). One patient 
presented with aphasia and fine motoric skills impairment on the left arm (CCT-scan: 
supraventricular white matter infarction), the symptoms were residual on discharge day (day 
15). Another  patient developed right sided hemiparesis (CCT-scan: left frontal border-zone 
infarction). This patient was able to walk after intensive physical therapy and was transferred 
to rehabilitation center on day 16. The third patient developed left side hemiparesis (CCT-
scan: left lentiform nucleus and paraventricular white matter infarction) and a discrete left 
motoric weakness was still present on discharge on day 24. CCT-scans were performed in two 
other patients because of delayed recovery of consciousness, with both showing cerebral 
infarction: one of these patients had epileptic seizures and a prolonged stay on the ICU, 
transfer to rehabilitation center occurred on day 76; the other patient developed mediastinitis 
and died in septic shock on day 38. 
Two patients had hemorrhagic stroke. One patient became comatose on day 5, CCT-scan 
showed cerebellum bleeding with cerebral edema and the patient died on the following day 
after transfer to a neurosurgical clinic. The other patient had LCOS with ECMO, IABP and 
biventricular assist device implantation with therapeutical anticoagulation. CCT-scan was 
performed because of anisocoria on day 15 and showed frontal lobe hemorrhage with cerebral 
compression and bleeding into the cerebral ventricles. This patient died on day 17. 
Temporary focal deficits lasting over 72 hours without imagiologic correlation occurred in 2 
patients (1%). Symptoms included sensorial and fine motor impairment of the right upper 
extremity and dizziness, transient aphasia and weakness of the right arm. Postoperative 
delirium was diagnosed in 16 patients (8.0%), in 3 patients concomitant with stroke.  
5.3.8 In-hospital stay 
Distribution of time-in-hospital is shown in Figure 2. Patients who survived 30 days after 
discharge stayed in hospital for 12 ± 10.5 days (median 9 days). Thirty-two patients (16.2%) 
were discharged on day 7 or earlier, 104 (52.3%) on day 9 or earlier and 140 (70.4%) on day 
12 or earlier. Thirty three patients (16.6%) had a length of stay longer than 14 days. 
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Figure 2: In-hospital stay for discharged patients, excluding the patients who died in the 
hospital and in the first month after discharge. 
 
 
 
 
 
 
 
5.4 Late postoperative results 
The mean follow up was 5.1 ± 3.6 years, ranging from 33 days to 14.4 years and was 98% 
complete.  
The estimated 10-year survival was 76 ± 4% with 1, 3 and 5-year survival being respectively 
93 ± 1.8%, 91 ± 2% and 86 ± 2.8. This is represented in Figure 3. 
Late death from probable cardiac causes occurred in one patient 5.3 years after surgery due to 
heart failure after pulmonary embolism.  
 
Figure 3: Kaplan Meier curve for long term cumulative survival. 
 
 
 
 
 
 
 
 
 
RESULTS 
38 
 
During follow-up, 10 patients underwent aortic related reoperations. The estimated freedom 
from aortic related re-operation was 93 ± 2% at 10 years. This is represented in Figure 4. 
Causes for reoperation were aortic valve endocarditis (2%, n=4), aortic valve regurgitation 
(1.5%, n=3), aortic valve prosthesis degeneration (0.5%, n=1) and aortic aneurysm (1%, n=2), 
one patient underwent a thoracoabdominal aortic replacement. 
 
Figure 4: Kaplan Meier curve for long term freedom of aortic related reoperations. 
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6 DISCUSSION 
This work describes one of the largest series of minimal access surgery of the proximal aorta 
to date and confirms the results already described in the literature. 
Minimal invasive surgery on the proximal aorta was first described by Svensson in 1997
72
. In 
the following year, this author included procedures on the aorta (6 patients with composite 
valve graft surgery including one with hemi-arch replacement, 2 patients with ascending aorta 
repair and 3 with aortic root reconstruction) among 37 other minimal access cases
24
. ”J/j” 
incision, incomplete median sternotomy, parasternal incision, transverse sternotomy and 
inverted “T” were performed. The author compared this population to 37 matched full 
sternotomy patients. It is unclear which minimal access was performed for the proximal aorta 
procedures. 
Other publications
37,58,61,73
 also included minimal access proximal aortic procedures as a 
subgroup: 
Byrne (2000)
61
 included 63 cases of proximal aortic surgery (44 aortic root replacements, 9 
aortic valve and supracoronary ascending aorta replacements and 10 isolated supracoronary 
ascending aorta replacements, including 3 aortic arch replacements) among a larger group of 
290 patients undergoing minimal invasive surgery from 1996 to 2000;  
Svensson (2002)
73
 targeted his publication to blood conservation and prevention of 
neurological deficit on procedures on the ascending aorta and aortic arch. Among a total of 
403 cases, 68 “J” incision patients were included;  
Tabata (2008)
37
 published about 1005 cases of minimal invasive aortic valve surgery, mostly 
through upper sternotomy, including 86 cases of Bentall root replacement and 62 cases of 
aortic valve and supracoronary ascending aorta replacement. 
Totaro (2009)
58
 included 241 cases of proximal aortic surgery among 1126 patients 
undergoing upper ministernotomy. The author splits the total cohort in three groups, including 
all the 241 proximal aortic surgery cases in a “complex cardiac surgery group” of 354 
patients, along with double-valve procedures, combined aortic valve replacements, coronary 
surgery and “complex redo procedures”. After describing the population and results from the 
ensemble, the author matched 24 of the “complex cardiac surgery group” to 24 full 
sternotomy patients and compared their outcome. Although this constitutes the largest cohort 
of minimal access aortic surgery cases, the results stated for the “complex cardiac surgery” 
group included 113 cases where ascending aorta surgery had not taken place. Also this latter 
DISCUSSION 
40 
 
group was not described in detail, lacking information about urgency of the surgery or initial 
population risk.  
Other studies focused directly in the description and results of minimal access proximal aortic 
surgery per se or in the comparison between it and full sternotomy.  
Svensson (2000)
74
 reported about 54 patients submitted to aortic surgery through “J” or “j” 
incisions (41 aortic valve replacements, 36 ascending aorta repairs, 18 ascending aorta and 
aortic arch repairs, including 3 cases of elephant trunk technique and a total of 15 cases of 
composite valve graft technique). In his population, reoperative surgery was performed in 18 
patients.  
Perrotta (2008)
75
 described 40 patients undergoing Bentall procedure, either through upper 
„J“ incision or reversed „T“ ministernotomy. This population included 9 reoperation cases, 
two patients undergoing hemiarch replacement and one having CABG as concomitant 
procedure. 
Sun
60
 and Shrestha
59
 reported about small groups of patients undergoing specific procedures 
(Sun (2000)
60
: 8 Marfan patients undergoing superior ministernotomy Bentall procedures 
compared to 21 standard median sternotomy Bentall patients;  Shrestha (2015)
59
 26 upper 
sternotomy compared to 14 full sternotomy David root repair patients, 4 proximal aortic arch 
replacements and 1 CABG were included). As for Tabata (2007)
62
, this author described 128 
consecutive patients undergoing proximal aortic surgery through ministernotomy, including 7 
aortic arch replacements, before comparing two matched cohorts of 79 patients each: a 
ministernotomy cohort selected from the above 128 patients matched to a full sternotomy 
group, both undergoing surgery of the ascending and proximal arch of the aorta. This study 
included the patients already described by Byrne (2000)
61
. 
One review paper was published by Perrotta and Lentini (2009)
63
. These authors searched 
for relevant literature concerning ministernotomy for surgery of the aortic root and ascending 
aorta from 1950 to 2009 and discussed the seven most relevant articles, all of them already 
cited in this work (Sun
60
, Svensson
74
, Svensson
73
, Byrne
61
, Perrotta
75
, Tabata
62
, Svensson
24
). 
The variety of design of the published papers, the limited size of the populations studied and 
the diversity of procedures included in the analysis as well as the disparity of the described 
populations turns the positioning and judgement of our results into a delicate task. 
In fact, the inclusion or higher risk procedures as aortic arch replacement or urgent procedures 
is limited on many publications. Tabata (2008)
37
 and Totaro (2009)
58
 do not specify if there 
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were proximal aortic procedures among their reoperative and non-elective cases included in 
their larger population of respectively 1005
37
 and 1126
58
 patients. The patients in the upper 
sternotomy group described by Shrestha
59
 were all aged less than 60 years and without 
comorbidities. 
Although Byrne
61
 stated the importance of well choosing the patients for minimal access 
surgery in regard to body habitus and chest conformation and primary selected high-risk and 
old patients for full sternotomy
61
, his population resulted in only a slighter lower fraction of 
higher-risk patients in the aortic surgery groups (dissection n=1 (1.6%); reoperations n=5 
(7.9%)) than ours (dissection n=5 (2.5%); reoperations n=17 (8.5%); urgent cases n=9 
(4.5%)). The discrepancy of the studied populations turns more evident when comparing our 
population to the hemisternotomy population by Tabata (2007)
62
 (aortic dissection n=1 
(0.8%); reoperations n=6 (4.7%); urgent cases n=5 (3.9%)). Despite of some similarities to 
our population, there is a marked difference between the fraction of aortic arch replacement 
cases included in both studies (n=3 (4.7%)
61
 and n=7 (5.5%)
62
) and in ours (n=52 (26.7%)). 
The smaller cohort from Svensson (2000)
74
 presented with a higher fraction of higher risk 
patients (aortic dissection n=16 (30%); reoperations n=18 (33%); aortic arch n=18 (33%)) 
than ours. Higher risk patients were also included by Perrotta (2008)
75
 (aortic dissection n=4 
(10%); reoperations n=8 (20%); aortic arch n=2 (5%)). 
Concerning the technique practiced in Heart Center Leipzig in the analyzed time span, no new 
innovative steps were described that had not already been described in the literature. There 
was limited information about some relevant details, as the chest-tube or pacemaker wire 
placing technique or the exact extent of the sternal incision and the adopted de-airing 
techniques. No major problems were described in the technical point of view, including 
cannulation for cardiopulmonary bypass, cardioplegia application of cerebral perfusion, 
showing that this procedure is feasible and safe and our low rates of low cardiac output, 
stroke and conversion to full sternotomy support this statement. 
It can be assumed that the application of cardioplegia is not a source of problems as only 2 
patients (1%) unexpectedly developed low cardiac output syndrome possibly due to apparent 
inadequate cardioplegia application and not due to accidental coronary artery lesions. Low 
rates of cardiac complications are also described in the literature, varying between 0% 
(Byrne)
61
 and 2.3% (Tabata 2007)
62
.  
In the same line of thought, the fact that no stroke occurred in patients undergoing total aortic 
arch replacement with cerebral perfusion confirms the success of this technique. Stroke rate 
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varies from 0%
61
 (Svensson 1998)
61
 to 5% (Perrotta 2008)
75
 and our  results (stroke rate 
2.5%) are consistent with these findings, in spite of including a higher fraction of aortic arch 
procedures. This brings even more confidence in the success of deairing techniques 
performed through ministernotomy and other midline minimal access incisions, after the 
initial scepsis of the early experience with minimal access aortic valve surgery. In 
contemporary results for proximal aortic replacement in North America
76
(45894 cases from 
2006 to 2009, no reference to type of access): stroke rate is as high as 6.6%
76
 when 
considering the ensemble of non-elective as well as elective surgeries.  
Low conversion rate (n=4 (2%)), with no cases of conversion because of primary inadequate 
exposure further confirms the feasibility of median minimal incisions for procedures on the 
proximal thoracic aorta. This already had been stated by Totaro
58
 about his conversion rate of 
1.4%
58
. Circumstances behind the need of conversion were well studied by Tabata
38
, who 
described the reasons to convert 24 patients (20 aortic valve replacements, 3 root 
replacements, 1 patch repair of aortic arch) out of 907 (2.6%) undergoing upper sternotomy 
for aortic valve or proximal aortic surgery. This author found the most frequent reason to 
convert to be bleeding in 0.9%, followed by ventricular dysfunction in 0.6%. Poor exposure 
was the reason to convert in 0.2%
38
. Citing this author, “the upper hemisternotomy provides 
excellent exposure of the aortic valve, root, ascending aorta and arch”38. Other authors 
describe conversion rates between 0%
59,74
 and 2.7%
37
.  
Surgical times are shorter in our cohort than in the publications where times for minimal 
access aortic procedures were discriminated. Mean cardiopulmonary bypass time for minimal 
access proximal aortic surgery was described to be as long as 176 ± 42 min in Shrestha
59’s 
series, while Svensson (2000)
74
 and Tabata (2007)
62
  report respectively 132 ± 59 min and  
152 ± 57 min. Byrne reports his results in median (range): 176 (133-330) min for the root 
replacement group and 135 (105-306) min and 132 (52-233) min respectively for the 
supracoronary replacement with and without replacement of the aortic valve. For Bentall-
procedure, Perrotta
75
 describes 153.6 ± 41.1 min cardiopulmonary bypass time and 107.5 ± 
20.3 min aortic cross clamp time. 
Our overall surgical times are also shorter than those reported 2012 in the contemporary 
results for proximal aortic replacement in North America
76
  (median (25
th
, 75
th
 percentile): 
total operation time 312 (246, 396) min,  aortic cross-clamp time 111 (79, 152) min), inferring 
that minimal access proximal aortic surgery does not have to be associated to longer 
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surgeries, at least in a high-volume center and with very experienced surgeons. Other authors 
had already described short surgical times in comparison to full sternotomy
58
. 
Our results show that concomitant procedures should no longer be considered a compelling 
reason for excluding ministernotomy as access site, as we successfully performed mitral valve 
repair, MAZE procedure, atrial septum defect repair and Morrow septal myectomy through 
this kind of access. This had already been described by other authors
37,58,74
. 
In addition to being feasible, minimal access proximal aortic surgery has been showing other 
promising short-term results in current publications, additionally to the rate of stroke and 
cardiac complications, which have already been discussed. 
Operative mortality for minimal access aortic surgery in the literature is stated to be between 
0% by Shrestha
59
 and 4.1% in the complex procedure group by Totaro
58
. Our cohort included 
a considerable fraction of higher risk patients, reflected on the high EuroSCORE II and on the 
high fraction of aortic arch procedures. Thus, 5.5% operative mortality is acceptably low. In 
fact, it is lower than the operative mortality for conventional sugery on the aortic root 
(n=12702, mortality 6.01%)
76
 and ascending aorta (n=22048, mortality 8.67%)
76
 groups 
reported 2012 in the contemporary results for proximal aortic replacement in North 
America
76
.  
In hospital stay is very frequently described in the literature. Hospital discharge was described 
to occur on postoperative days 6.7 ± 3.7 (Svensson 2000)
74
 to 12 ± 8 (Totaro)
58
. Byrne
61
 
present his results as median length of stay of 5 days
62
 for both the root replacement and the 
aortic valve and supracoronary aortic replacement groups and 8 days
61
 for the isolated 
supracoronary aortic replacement. For those authors who compared minimal access to full 
sternotomy, length of stay was shorter for the minimal access group
62
.  
In contemporary results for proximal aortic replacement in North America
76
 only prolonged 
length of stay (over 14 days) was stated (15.7% of the overall population and 9.3% of the 
elective cases). Our patients stayed longer in the hospital (length of stay 12 ± 10 days, median 
9 days, 16.6% stayed longer than 14 days). This may be related to our strategy of transferring 
all patients directly to a rehabilitation center, which takes some extra planning time. Other 
authors58 failed to confirm reduced hospital stay for minimal access proximal aortic surgery 
comparing to full sternotomy patients. 
We consider that our cases of reexploration because of bleeding (n= 26 (13.1%)) could be 
explained by a coagulopathic state.  
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First, our patients had a moderate-to-high risk, reflected in an additive EuroSCORE II of 5.0 ± 
2.0. A higher EuroSCORE has already been considered as a predictor for reoperation due to 
bleeding by Kristensen
77
. Predictors for higher bleeding risk after cardiac surgery that are 
involved in EuroSCORE II calculation in the literature include low ejection fraction
77
, 
procedures other than isolated CABG
77,78
, diabetes mellitus
77
, preoperatively elevated serum 
creatinine
77
, higher age
78,79,80
 and priority status
78,79
.  Patients with higher patient-associated 
risk profile are more often medicated with antiplatelet or anticoagulant therapy, which might 
also increase the bleeding risk after cardiac surgery
79,81
.  
Secondly, according to a paper by Rivera
82
, cardiopulmonary bypass is a well-known inductor 
of systemic inflammatory response syndrome (SIRS) through the activation of the 
complement, coagulation and fibrinolytic systems due to interaction of blood with the foreign 
surfaces of the machine and tubes
82
. This results in molecular pathways and activated cells 
that are responsible for the clinical manifestations of SIRS, including bleeding
82
. In fact, 
prolonged cardiopulmonary bypass times have been associated with a higher risk for bleeding 
in cardiac surgery
77,80
.  
Thirdly, we believe that bleeding risk may be increased on the postoperative setting due to 
more or less aggressive anticoagulation schemes.  
On his study on the reasons to convert minimal access to full sternotomy,  Tabata
38
 described 
the cannulation site as the bleeding source that led to conversion in more than half of the 
patients who were converted because of bleeding
38
. In our cohort, no bleeding from 
cannulation site occurred. Instead, bleeding from proximal and distal anastomosis was more 
often, turning out to be the cause of conversion in n=2 (1%) and of surgical reexploration in 
n=12 (6%) of the patients. We believe that a pathological coagulation state may cause an at 
first well-sutured anastomosis to leak.  
Indication to reexplore because of bleeding is not standardized in our clinic and the decision 
to reoperate was made individually by the operating surgeon or the surgeon on-call, meaning 
that discrepancies are likely to occur when comparing our results to other publications. Lower 
rates of reexploration because of bleeding were reported, varying between 1.6% for Tabata 
2007
62
 and 11% for Byrne
61
. 
Information on preoperative coagulation status and medication, intraoperative and 
postoperative vital parameter (blood pressure, temperature) and anticoagulation scheme, as 
well as chest tube output were not available for study.  
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Isolated papers reported only the cases undergoing reexplorative surgery because of bleeding 
if it occurred in a specific period after initial surgery
77,83
. In contrast, we considered all 
reexplorative surgery because of bleeding on the operation site occurring in the whole 
hospitalization period. None of the papers on minimal access proximal aortic surgery clarified 
their definition on this subject.  
We emphasize the low frequency of sternal complications with only 1 patient (0.5%) 
developing deep sternal wound infection, showing that patients at risk for these complications 
may profit from this approach. Our results are in consonance with the literature, where a low 
rate of sternal complications is stated by Byrne (0%-2.3%)
61
 and Tabata (0.8%
62
 and 0.5%
37
). 
Better sternal stability is assumed to improve respiratory function and mobility after 
surgery
37
, despite of lacking of concrete data on this subject for proximal aortic surgery. In 
fact, reports on respiratory parameter are scarce among minimal access proximal aortic 
surgery results and are difficult to compare due to differences of definition. In contemporary 
results for proximal aortic replacement in North America
76
, prolonged ventilation was 
defined as ventilation longer than 24 hours and this was the case in 27.8% of the patients. 
Ventilation time for the complex group of Totaro
58
 (35 ± 66 hours) was longer and the rate of 
ventilation time over 24 hours (20.4%) higher than in our series (respectively 18 ± 30 hours 
and 12.3%). Perrotta
75
 describes a mechanical ventilation time of 52.7 ± 187.1 hours. 
Although frequency of pneumonia and tracheostomy in our cohort (respectively 3% and 2%) 
were lower than for the control group in a publication by Miyahara (respectively 6.8% and 
2.8%)
84
, who reported the outcomes of patients with and without chronic obstructive 
pulmonary disease after total arch replacement through full sternotomy, in our cohort, more 
patients were ventilated over 48 hours than those control patients (13.5% versus 5.7%)
84
. 
These discrepancies could result from different intensive care and perioperative strategies 
(fast-track protocols), but again, vital and other intensive care parameters were not available 
for analysis.  Nonetheless, we believe that patients at risk for pulmonary complications could 
profit from a minimal access when undergoing proximal aortic surgery, as had already been 
stated for aortic valve procedures by  Svensson
24
   and von Segesser
2
. 
Especially the redo population has also been described to benefit from minimal access surgery 
on the proximal aorta, as adhesions on the non-exposed areas of the heart do not need to be 
dissected
74
 thus reducing the risk of lesions of coronary bypass grafts and the myocardium 
itself
74
. We were still not successful on proving this, as our population did not include enough 
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redo patients to produce consistent results. Even though this is widely accepted, some centers 
consider minimal access to be contraindicated for patients undergoing redo procedures
59
. 
We present the first long term results for minimal access proximal aortic surgery at 10 years, 
including mortality and freedom from aortic related reoperations. Only Perrotta
75
 also 
reported long term survival rates, (comparable to ours respectively 94.1%, 90.6% and 90.6% 
for 1, 3 and 5 year survival), but no information about 10 year freedom from reoperation after 
minimal access aortic surgery was found in the literature. 
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7 CONCLUSION 
We reviewed the techniques of minimal invasive surgery on the thoracic aorta performed on 
199 patients in Heart Center Leipzig. The majority of the patients had elective surgery 
because of dilatation of the proximal aorta associated to pathology of the aortic valve. This 
was performed mostly through L-type partial sternotomy. All surgeries were completed with a 
standard surgical setup.  
Our results show low mortality and morbidity despite of increased rate of bleeding 
complications. Although extended aortic surgery was performed, conversion to full 
sternotomy was only necessary in few isolated cases. Long term mortality and aortic related 
reoperations were also low. 
Our results are comparable to what has been described in the literature so far but we believe 
that our results are more realistic and reflect better the risk inherent to minimal access 
proximal aortic surgery than studies with smaller cohorts.  
We recognize that our study is limited by its retrospective form and that the heterogeneity of 
the described procedures makes a precise analysis difficult. Randomized prospective studies 
as well as comparative studies with full sternotomy should bring more information about the 
safety of this procedure, but we are already able to support ministernotomy as a promising 
access for selected patients nowadays and in the future. 
REFERENCES 
48 
 
8 REFERENCES 
 
1. Rao, P. N. & Kumar, A. S. Aortic valve replacement through right thoracotomy. Tex. 
Heart Inst. J. Tex. Heart Inst. St Lukes Episcop. Hosp. Tex. Child. Hosp. 20, 307–308 
(1993). 
2. von Segesser, L. K. et al. Less invasive aortic valve surgery: rationale and technique. Eur. 
J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 15, 781–785 (1999). 
3. Estrera, A. L. & Reardon, M. J. Current approaches to minimally invasive aortic valve 
surgery. Curr. Opin. Cardiol. 15, 91–95 (2000). 
4. Cosgrove, D. M. & Sabik, J. F. Minimally invasive approach for aortic valve operations. 
Ann. Thorac. Surg. 62, 596–7 (1996). 
5. Lazzara, R. R. & Kidwell, F. E. Right parasternal incision: a uniform minimally invasive 
approach for valve operations. Ann. Thorac. Surg. 65, 271–272 (1998). 
6. Iribarne, A. et al. The golden age of minimally invasive cardiothoracic surgery: current 
and future perspectives. Future Cardiol. 7, 333–346 (2011). 
7. Cosgrove, D. M., Sabik, J. F. & Navia, J. L. Minimally invasive valve operations. Ann. 
Thorac. Surg. 65, 1535–1538; discussion 1538–1539 (1998). 
8. Kasegawa, H. [Minimally invasive mitral surgery: mitral valve repair with a right-sided 
partial sternotomy]. Nihon Geka Gakkai Zasshi 99, 817–820 (1998). 
9. Lamelas, J. Minimally invasive aortic valve replacement: the ‘Miami Method’. Ann. 
Cardiothorac. Surg. 4, 71–77 (2015). 
10. Nair, R. U. & Sharpe, D. A. Minimally invasive reversed Z sternotomy for aortic valve 
replacement. Ann. Thorac. Surg. 65, 1165–1166 (1998). 
11. Konertz, W., Waldenberger, F., Schmutzler, M., Ritter, J. & Liu, J. Minimal access valve 
surgery through superior partial sternotomy: a preliminary study. J. Heart Valve Dis. 5, 
638–640 (1996). 
12. Mihaljevic, T. et al. One thousand minimally invasive valve operations: early and late 
results. Ann. Surg. 240, 529–534; discussion 534 (2004). 
13. Farhat, F. et al. Prospective comparison between total sternotomy and ministernotomy for 
aortic valve replacement. J. Card. Surg. 18, 396–401; discussion 402–403 (2003). 
14. Cohn, L. H. et al. Minimally invasive cardiac valve surgery improves patient satisfaction 
while reducing costs of cardiac valve replacement and repair. Ann. Surg. 226, 421–426; 
discussion 427–428 (1997). 
REFERENCES 
49 
 
15. Bridgewater, B., Steyn, R. S., Ray, S. & Hooper, T. Minimally invasive aortic valve 
replacement through a transverse sternotomy: a word of caution. Heart Br. Card. Soc. 79, 
605–607 (1998). 
16. Rodríguez, J. E. et al. [Aortic valve replacement via ministernotomy]. Rev. Esp. Cardiol. 
49, 928–930 (1996). 
17. Christiansen, S. et al. Minimally-invasive versus conventional aortic valve replacement--
perioperative course and mid-term results. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. 
Assoc. Cardio-Thorac. Surg. 16, 647–652 (1999). 
18. Mächler, H. E. et al. Minimally invasive versus conventional aortic valve operations: a 
prospective study in 120 patients. Ann. Thorac. Surg. 67, 1001–1005 (1999). 
19. Aris, A. Reversed ‘C’ ministernotomy for aortic valve replacement. Ann. Thorac. Surg. 
67, 1806–1807 (1999). 
20. Ariyaratnam, P., Loubani, M. & Griffin, S. C. Minimally invasive aortic valve 
replacement: Comparison of long-term outcomes. Asian Cardiovasc. Thorac. Ann. 
(2015). doi:10.1177/0218492315587606 
21. Szwerc, M. F. et al. Partial versus full sternotomy for aortic valve replacement. Ann. 
Thorac. Surg. 68, 2209–2213; discussion 2213–2214 (1999). 
22. Glauber, M., Ferrarini, M. & Miceli, A. Minimally invasive aortic valve surgery: state of 
the art and future directions. Ann. Cardiothorac. Surg. 4, 26–32 (2015). 
23. Murzi, M. & Glauber, M. Central versus femoral cannulation during minimally invasive 
aortic valve replacement. Ann. Cardiothorac. Surg. 4, 59–61 (2015). 
24. Svensson, L. G. & D’Agostino, R. S. Minimal-access aortic and valvular operations, 
including the ‘J/j’ incision. Ann. Thorac. Surg. 66, 431–435 (1998). 
25. Lehmann, S. et al. Minimally invasive aortic valve replacement: the Leipzig experience. 
Ann. Cardiothorac. Surg. 4, 49–56 (2015). 
26. Dogan, S. et al. Minimally invasive versus conventional aortic valve replacement: a 
prospective randomized trial. J. Heart Valve Dis. 12, 76–80 (2003). 
27. Doll, N. et al. Minimal access aortic valve replacement: effects on morbidity and resource 
utilization. Ann. Thorac. Surg. 74, S1318–1322 (2002). 
28. Bakir, I. et al. Minimally invasive versus standard approach aortic valve replacement: a 
study in 506 patients. Ann. Thorac. Surg. 81, 1599–1604 (2006). 
29. Bonacchi, M., Prifti, E., Giunti, G., Frati, G. & Sani, G. Does ministernotomy improve 
postoperative outcome in aortic valve operation? A prospective randomized study. Ann. 
Thorac. Surg. 73, 460–465; discussion 465–466 (2002). 
REFERENCES 
50 
 
30. Gundry, S. R. et al. Facile minimally invasive cardiac surgery via ministernotomy. Ann. 
Thorac. Surg. 65, 1100–1104 (1998). 
31. Johnston, D. R. & Roselli, E. E. Minimally invasive aortic valve surgery: Cleveland 
Clinic experience. Ann. Cardiothorac. Surg. 4, 140–147 (2015). 
32. Doty, D. B., DiRusso, G. B. & Doty, J. R. Full-spectrum cardiac surgery through a 
minimal incision: mini-sternotomy (lower half) technique. Ann. Thorac. Surg. 65, 573–
577 (1998). 
33. Moreno-Cabral, R. J. Mini-T sternotomy for cardiac operations. J. Thorac. Cardiovasc. 
Surg. 113, 810–811 (1997). 
34. Karimov, J. H., Santarelli, F., Murzi, M. & Glauber, M. A technique of an upper V-type 
ministernotomy in the second intercostal space. Interact. Cardiovasc. Thorac. Surg. 9, 
1021–1022 (2009). 
35. Boehm, J., Libera, P., Will, A., Martinoff, S. & Wildhirt, S. M. Partial median ‘I’ 
sternotomy: minimally invasive alternate approach for aortic valve replacement. Ann. 
Thorac. Surg. 84, 1053–1055 (2007). 
36. Burdett, C. L. et al. Manubrium-limited sternotomy decreases blood loss after aortic valve 
replacement surgery. Interact. Cardiovasc. Thorac. Surg. 19, 605–610 (2014). 
37. Tabata, M. et al. Early and late outcomes of 1000 minimally invasive aortic valve 
operations. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 33, 
537–541 (2008). 
38. Tabata, M. et al. Conversion to full sternotomy during minimal-access cardiac surgery: 
reasons and results during a 9.5-year experience. J. Thorac. Cardiovasc. Surg. 134, 165–
169 (2007). 
39. Aris, A. et al. Ministernotomy versus median sternotomy for aortic valve replacement: a 
prospective, randomized study. Ann. Thorac. Surg. 67, 1583–1587; discussion 1587–1588 
(1999). 
40. Bonacchi, M., Prifti, E., Giunti, G., Frati, G. & Sani, G. Does ministernotomy improve 
postoperative outcome in aortic valve operation? A prospective randomized study. Ann. 
Thorac. Surg. 73, 460–465; discussion 465–466 (2002). 
41. Raja, S. G., Benedetto, U. & Amrani, M. Aortic valve replacement through J-shaped 
partial upper sternotomy. J. Thorac. Dis. 5 Suppl 6, S662–668 (2013). 
42. Neely, R. C. et al. Minimally invasive aortic valve replacement versus aortic valve 
replacement through full sternotomy: the Brigham and Women’s Hospital experience. 
Ann. Cardiothorac. Surg. 4, 38–48 (2015). 
REFERENCES 
51 
 
43. van der Merwe, J. et al. Minimally invasive primary aortic valve surgery: the OLV Aalst 
experience. Ann. Cardiothorac. Surg. 4, 154–159 (2015). 
44. Ehrlich, W., Skwara, W., Klövekorn, W., Roth, M. & Bauer, E. P. Do patients want 
minimally invasive aortic valve replacement? Eur. J. Cardio-Thorac. Surg. Off. J. Eur. 
Assoc. Cardio-Thorac. Surg. 17, 714–717 (2000). 
45. Malaisrie, S. C. et al. Current era minimally invasive aortic valve replacement: techniques 
and practice. J. Thorac. Cardiovasc. Surg. 147, 6–14 (2014). 
46. Sharony, R. et al. Propensity score analysis of a six-year experience with minimally 
invasive isolated aortic valve replacement. J. Heart Valve Dis. 13, 887–893 (2004). 
47. Masiello, P. et al. Surgical results of aortic valve replacement via partial upper 
sternotomy: comparison with median sternotomy. Cardiovasc. Surg. Lond. Engl. 10, 333–
338 (2002). 
48. Liu, J., Sidiropoulos, A. & Konertz, W. Minimally invasive aortic valve replacement 
(AVR) compared to standard AVR. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. 
Cardio-Thorac. Surg. 16 Suppl 2, S80–83 (1999). 
49. Candaele, S., Herijgers, P., Demeyere, R., Flameng, W. & Evers, G. Chest pain after 
partial upper versus complete sternotomy for aortic valve surgery. Acta Cardiol. 58, 17–
21 (2003). 
50. Albacker, T. B. et al. Should less-invasive aortic valve replacement be avoided in patients 
with pulmonary dysfunction? J. Thorac. Cardiovasc. Surg. 147, 355–361.e5 (2014). 
51. Authors/Task Force members et al. 2014 ESC Guidelines on the diagnosis and treatment 
of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic 
and abdominal aorta of the adult * The Task Force for the Diagnosis and Treatment of 
Aortic Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 35, 2873–
2926 (2014). 
52. Hiratzka, L. F. et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM 
Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: 
Executive Summary. J. Am. Coll. Cardiol. 55, 1509–1544 (2010). 
53. Davis, A. E. et al. Observational study of regional aortic size referenced to body size: 
production of a cardiovascular magnetic resonance nomogram. J. Cardiovasc. Magn. 
Reson. 16, 9 (2014). 
54. Isselbacher, E. M. Thoracic and Abdominal Aortic Aneurysms. Circulation 111, 816–828 
(2005). 
55. Gornik, H. L. & Creager, M. A. Aortitis. Circulation 117, 3039–3051 (2008). 
REFERENCES 
52 
 
56. Leontyev, S., Misfeld, M. & Mohr, F. W. Aneurysmen der Aorta ascendens und des 
Aortenbogens. Chir. 85, 758–766 (2014). 
57. Ergin, M. A. et al. Surgical treatment of the dilated ascending aorta: when and how? Ann. 
Thorac. Surg. 67, 1834–1839; discussion 1853–1856 (1999). 
58. Totaro, P. et al. Minimally invasive approach for complex cardiac surgery procedures. 
Ann. Thorac. Surg. 88, 462–466; discussion 467 (2009). 
59. Shrestha, M. et al. Minimally invasive valve sparing aortic root replacement (David 
procedure) is safe. Ann. Cardiothorac. Surg. 4, 148–153 (2015). 
60. Sun, L. et al. Aortic root replacement by ministernotomy: technique and potential benefit. 
Ann. Thorac. Surg. 70, 1958–1961 (2000). 
61. Byrne, J. G., Karavas, A. N., Cohn, L. H. & Adams, D. H. Minimal access aortic root, 
valve, and complex ascending aortic surgery. Curr. Cardiol. Rep. 2, 549–557 (2000). 
62. Tabata, M. et al. Minimal Access Surgery of Ascending and Proximal Arch of the Aorta: 
A 9-Year Experience. Ann. Thorac. Surg. 84, 67–72 (2007). 
63. Perrotta, S. & Lentini, S. Ministernotomy approach for surgery of the aortic root and 
ascending aorta. Interact. Cardiovasc. Thorac. Surg. 9, 849–858 (2009). 
64. Yan, T. D. Mini-Bentall procedure and hemi-arch replacement. Ann. Cardiothorac. Surg. 
4, 208–209 (2015). 
65. Akins, C. W. et al. Guidelines for Reporting Mortality and Morbidity After Cardiac Valve 
Interventions. Ann. Thorac. Surg. 85, 1490–1495 (2008). 
66. Bojar, R. M. Manual of perioperative care in adult cardiac surgery. (Wiley-Blackwell, 
2011). 
67. Data specification of the Society of thoracic surgeons. 
68. Hagl, C. et al. Neurologic outcome after ascending aorta-aortic arch operations: effect of 
brain protection technique in high-risk patients. J. Thorac. Cardiovasc. Surg. 121, 1107–
1121 (2001). 
69. Canver, C. C. & Chanda, J. Intraoperative and postoperative risk factors for respiratory 
failure after coronary bypass. Ann. Thorac. Surg. 75, 853–857; discussion 857–858 
(2003). 
70. Borde, D., Gandhe, U., Hargave, N., Pandey, K. & Khullar, V. The application of 
European system for cardiac operative risk evaluation II (EuroSCORE II) and Society of 
Thoracic Surgeons (STS) risk-score for risk stratification in Indian patients undergoing 
cardiac surgery. Ann. Card. Anaesth. 16, 163 (2013). 
REFERENCES 
53 
 
71. Yan, T. D. et al. Consensus on hypothermia in aortic arch surgery. Ann. Cardiothorac. 
Surg. 2, 163–168 (2013). 
72. Svensson, L. G. Minimal-access ‘J’ or ‘j’ sternotomy for valvular, aortic, and coronary 
operations or reoperations. Ann. Thorac. Surg. 64, 1501–1503 (1997). 
73. Svensson, L. G. Progress in ascending and aortic arch surgery: minimally invasive 
surgery, blood conservation, and neurological deficit prevention. Ann. Thorac. Surg. 74, 
S1786–1788; discussion S1792–1799 (2002). 
74. Svensson, L. G., Nadolny, E. M. & Kimmel, W. A. Minimal access aortic surgery 
including re-operations. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. 
Surg. 19, 30–33 (2001). 
75. Perrotta, S. et al. Treatment of ascending aorta disease with Bentall-De Bono operation 
using a mini-invasive approach. J. Cardiovasc. Med. Hagerstown Md 9, 1016–1022 
(2008). 
76. Williams, J. B. et al. Contemporary results for proximal aortic replacement in North 
America. J. Am. Coll. Cardiol. 60, 1156–1162 (2012). 
77. Kristensen, K. L., Rauer, L. J., Mortensen, P. E. & Kjeldsen, B. J. Reoperation for 
bleeding in cardiac surgery. Interact. Cardiovasc. Thorac. Surg. 14, 709–713 (2012). 
78. Vuylsteke, A. et al. The Papworth Bleeding Risk Score: a stratification scheme for 
identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur. 
J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 39, 924–930 (2011). 
79. Karthik, S., Grayson, A. D., McCarron, E. E., Pullan, D. M. & Desmond, M. J. 
Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, 
and the effect of time delay. Ann. Thorac. Surg. 78, 527–534; discussion 534 (2004). 
80. Karkouti, K., O’Farrell, R., Yau, T. M., Beattie, W. S. & Reducing Bleeding in Cardiac 
Surgery Research Group. Prediction of massive blood transfusion in cardiac surgery. Can. 
J. Anaesth. J. Can. Anesth. 53, 781–794 (2006). 
81. McDonald, S. B. et al. Preoperative use of enoxaparin increases the risk of postoperative 
bleeding and re-exploration in cardiac surgery patients. J. Cardiothorac. Vasc. Anesth. 19, 
4–10 (2005). 
82. Jimenez Rivera, J. J. et al. Factors associated with excessive bleeding in cardiopulmonary 
bypass patients: a nested case-control study. J. Cardiothorac. Surg. 2, 17 (2007). 
83. Toumpoulis, I. K., Anagnostopoulos, C. E., DeRose, J. J. & Swistel, D. G. Does 
EuroSCORE predict length of stay and specific postoperative complications after 
coronary artery bypass grafting? Int. J. Cardiol. 105, 19–25 (2005). 
REFERENCES 
54 
 
84. Miyahara, S. et al. Influences of chronic obstructive pulmonary disease on outcomes of 
total arch replacement. Ann. Thorac. Surg. 99, 72–78 (2015). 
 
ERKLÄRUNG ÜBER DIE EIGENSTÄNDIGE ABFASSUNG DER ARBEIT 
55 
 
9 ERKLÄRUNG ÜBER DIE EIGENSTÄNDIGE ABFASSUNG DER ARBEIT  
 
Hiermit erkläre ich, dass ich die vorliegende Arbeit selbstständig und ohne unzulässige Hilfe 
oder Benutzung anderer als der angegebenen Hilfsmittel angefertigt habe. Ich versichere, dass 
Dritte von mir weder unmittelbar noch mittelbar eine Vergütung oder geldwerte Leistungen 
für Arbeiten erhalten haben, die im Zusammenhang mit dem Inhalt der vorgelegten 
Dissertation stehen, und dass die vorgelegte Arbeit weder im Inland noch im Ausland in 
gleicher oder ähnlicher Form einer anderen Prüfungsbehörde zum Zweck einer Promotion 
oder eines anderen Prüfungsverfahrens vorgelegt wurde. Alles aus anderen Quellen und von 
anderen Personen übernommene Material, das in der Arbeit verwendet wurde oder auf das 
direkt Bezug genommen wird, wurde als solches kenntlich gemacht. Insbesondere wurden 
alle Personen genannt, die direkt an der Entstehung der vorliegenden Arbeit beteiligt waren. 
Die aktuellen gesetzlichen Vorgaben in Bezug auf die Zulassung der klinischen Studien, die 
Bestimmungen des Tierschutzgesetzes, die Bestimmungen des Gentechnikgesetzes und die 
allgemeinen Datenschutzbestimmungen wurden eingehalten. Ich versichere, dass ich die 
Regelungen der Satzung der Universität Leipzig zur Sicherung guter wissenschaftlicher 
Praxis kenne und eingehalten habe. 
 
 
 
 
Datum       Unterschrift
AKADEMISCHER, WISSENSCHAFTLICHER UND BERUFLICHER WERDEGANG 
56 
 
 
10 AKADEMISCHER, WISSENSCHAFTLICHER UND BERUFLICHER WERDEGANG 
 
Biographische Daten 
Joana Hiegel, geboren Estácio Fernandes Pinto  
geb. 15. Februar 1986 in Stuttgart.  
 
Hochschulausbildung 
09/2004 – 06/2010 
Humanmedizinstudium in Faculdade de Ciencias Médicas der 
Universidade Nova de Lisboa (Lissabon, Portugal) 
09/2008 – 08/2009 Austauschjahr “Erasmus” (Charité Berlin) 
07/2010 Hochschulabschluss mit Note 17/20  
10/2010 
Erlaubnis zur Ausübung des ärztlichen Berufes als  
Ärztin in Weiterbildung in Deutschland 
02/2013 Deutsche Approbation als Ärztin 
 
Ärztliche Tätigkeiten 
10/2010 – 10/2012 Assistenzärztin für Herzchirurgie (Herzzentrum Leipzig) 
11/2012 – 04/2013 Assistenzärztin für Anästhesie (Herzzentrum Leipzig) 
05/2013 – 03/2015 Assistenzärztin für Anästhesie (Universitätsklinik Leipzig) 
04/2015 – 11/2016 Assistenzärztin für Anästhesie (Helios Klinik Schkeuditz) 
seit 12/2016 Fachärztin für Anästhesie (Helios Klinik Schkeuditz) 
 
Publikationen, Vorträge, Facharztbezeichnung 
01/2011 
Publikation:  
Estacio J., Cardoso J.,  
Dilated cardiomiopathy – new therapeutic approach.  
Revista Sociedade Portuguesa de Medicina Interna 18 n° 1, 55-8 (2011)  
02/2012 
Vortrag:  
zum 41. Jahrestagung Deutsche Gesellschaft für  
Thorax- Herz- und Gefäßchirurgie (DGTHG): 
Early and mid-term results after minimally invasive proximal thoracic 
aortic operations in 199 patients 
11/2016 Fachärztin für Anästhesie 
 
 
